Statement,Assertion,Summary (Tavily Answer),Relevant Docs,Final Verdict,Full Analysis,Citations
"The tumor microenvironment (TME) is a complex, dynamic ecosystem surrounding malignant cells that plays a crucial role in cancer initiation, progression, and metastasis.","Tumor microenvironment (TME) plays a crucial role in cancer initiation, progression, and metastasis.",The tumor microenvironment influences cancer progression and metastasis through immune cell interactions and ECM mechanics. Macrophages and fibroblasts in the TME support cancer cell invasiveness and drug resistance. The TME's complexity drives cancer cell survival and spread.,"1. Role of tumor microenvironment in cancer progression and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10242329/
2. The Role of Tumor Microenvironment in Cancer Metastasis - https://pmc.ncbi.nlm.nih.gov/articles/PMC8122975/",Correct,"The TAVILY_SUMMARY explicitly states that the tumor microenvironment (TME) influences cancer progression and metastasis, and its complexity drives cancer cell survival and spread. The relevant documents also directly address the TME's role in cancer progression and metastasis.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10242329/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8122975/']"
"The TME, the environment surrounding the cancer cells, is a heterogeneous mixture of immune cells, endothelial cells, materials secreted from cells and their organelles, and fibroblasts.","Tumor microenvironment (TME) is a heterogeneous mixture including immune cells, endothelial cells, secreted materials, and fibroblasts.","The tumor microenvironment (TME) includes immune cells, fibroblasts, blood vessels, and extracellular matrix. Immune cells can either suppress or promote tumor growth. Cancer-associated fibroblasts play a role in tumor progression.","1. Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/
2. Cellular and Extracellular Components in Tumor Microenvironment ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7199555/",Correct,"The TAVILY_SUMMARY confirms that the tumor microenvironment (TME) includes immune cells, fibroblasts, blood vessels (implying endothelial cells), and extracellular matrix (which includes secreted materials).","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7199555/']"
"The tumor microenvironment (TME) is a complex biological structure surrounding tumor cells and includes blood vessels, immune cells, fibroblasts, adipocytes, and extracellular matrix (ECM).","Tumor microenvironment (TME) components include blood vessels, immune cells, fibroblasts, adipocytes, and extracellular matrix (ECM).","The tumor microenvironment includes blood vessels, immune cells, fibroblasts, and extracellular matrix. Immune cells can either suppress or promote tumor growth. The ECM supports tumor growth and influences immune cell behavior.","1. Extracellular Matrix in the Tumor Microenvironment and Its Impact on ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7025524/
2. Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/",Correct,"The TAVILY_SUMMARY confirms that the tumor microenvironment includes blood vessels, immune cells, fibroblasts, and extracellular matrix. While adipocytes are not explicitly mentioned in the provided summary or knowledge base excerpts, the other listed components are directly supported, and adipocytes are recognized components of the TME in cancer biology.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7025524/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/']"
"Within a tumor, cancer cells are surrounded by a variety of immune cells, fibroblasts, molecules, and blood vessels -- what's known as the tumor microenvironment.","Cancer cells within a tumor are surrounded by immune cells, fibroblasts, molecules, and blood vessels, forming the tumor microenvironment.","The tumor microenvironment includes immune cells, fibroblasts, blood vessels, and extracellular matrix. Immune cells can either suppress or promote tumor growth. Tumor-associated macrophages can promote angiogenesis and tumor progression.","1. Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/
2. Crosstalk between cancer and immune cells: Role of tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6712467/",Correct,"The TAVILY_SUMMARY explicitly states that the tumor microenvironment includes immune cells, fibroblasts, blood vessels, and extracellular matrix (which encompasses various molecules). This directly supports the assertion that cancer cells are surrounded by these components.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6712467/']"
"Cancer cells can change the microenvironment, which in turn can affect how cancer grows and spreads.","Cancer cells can alter the tumor microenvironment, influencing cancer growth and spread.","Cancer cells alter the microenvironment, promoting growth and spread. This interaction influences tumor progression and metastasis. The microenvironment's bidirectional communication is crucial for cancer development.","1. Role of tumor microenvironment in cancer progression and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10242329/
2. Microenvironmental regulation of tumor progression and metastasis - https://pmc.ncbi.nlm.nih.gov/articles/PMC3954707/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Cancer cells alter the microenvironment, promoting growth and spread' and that this interaction influences tumor progression and metastasis, highlighting the crucial role of bidirectional communication.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10242329/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3954707/']"
Cancer-associated fibroblasts (CAFs) represent one of the most abundant and functionally important components of the tumor stroma.,Cancer-associated fibroblasts (CAFs) are abundant and functionally important components of the tumor stroma.,Cancer-associated fibroblasts (CAFs) significantly influence tumor growth and metastasis. They secrete factors that support tumor progression and therapy resistance. CAFs can either promote or suppress tumor immunity.,"1. Cancer-Associated Fibroblasts: Master Tumor Microenvironment ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10047485/
2. Cancer associated fibroblasts: An essential role in the tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5588104/",Correct,"The TAVILY_SUMMARY indicates that Cancer-associated fibroblasts (CAFs) 'significantly influence tumor growth and metastasis' and 'secrete factors that support tumor progression and therapy resistance,' confirming their functional importance. The titles of the relevant documents also suggest their significant role.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10047485/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5588104/']"
"Cancer-associated fibroblasts (CAFs), a major component of the tumor microenvironment (TME), play an important role in cancer initiation, progression, and metastasis.","Cancer-associated fibroblasts (CAFs) play an important role in cancer initiation, progression, and metastasis within the TME.","Cancer-associated fibroblasts (CAFs) significantly influence tumor growth, invasion, and metastasis. They modulate the tumor microenvironment and affect immune response. Targeting CAFs shows promise in cancer treatment.","1. Cancer-Associated Fibroblasts: Master Tumor Microenvironment ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10047485/
2. Revisiting the role of cancer-associated fibroblasts in tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12043473/",Correct,"The TAVILY_SUMMARY explicitly states that Cancer-associated fibroblasts (CAFs) 'significantly influence tumor growth, invasion, and metastasis,' directly supporting their important role in cancer progression and metastasis.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10047485/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12043473/']"
"Unlike normal fibroblasts, CAFs exhibit markedly different characteristics that promote tumorigenesis.",Cancer-associated fibroblasts (CAFs) possess characteristics distinct from normal fibroblasts that promote tumorigenesis.,"Cancer-associated fibroblasts (CAFs) promote tumor growth, angiogenesis, and metastasis through various factors. CAFs differ from normal fibroblasts by secreting growth factors and cytokines. CAFs contribute to therapy resistance and tumor progression.","1. Cancer associated fibroblasts: An essential role in the tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5588104/
2. Their Characteristics and Their Roles in Tumor Growth - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4695902/",Correct,"The TAVILY_SUMMARY explicitly states that 'CAFs differ from normal fibroblasts by secreting growth factors and cytokines' and that they 'promote tumor growth, angiogenesis, and metastasis,' confirming they possess distinct characteristics that promote tumorigenesis.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5588104/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4695902/']"
"As is evident from their large number of mitochondria, fibroblasts are very metabolically active, continuously synthesizing elements of the extracellular matrix and collagen.","Fibroblasts are metabolically active, synthesizing extracellular matrix elements and collagen, evidenced by numerous mitochondria.","Fibroblasts are highly metabolically active due to their large mitochondria, synthesizing collagen and extracellular matrix components continuously. Mitochondria support their energy needs for these functions.","1. Extracellular Matrix and Dermal Fibroblast Function in the Healing ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4779293/
2. Role of mitochondria in physiological activities, diseases, and therapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC12179052/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Fibroblasts are highly metabolically active due to their large mitochondria, synthesizing collagen and extracellular matrix components continuously. Mitochondria support their energy needs for these functions.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4779293/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12179052/']"
"Tissue damage is a major trigger for the activation of fibroblasts from fibrocytes, and so fibroblasts play an important role in wound healing.","Tissue damage triggers fibroblast activation from fibrocytes, making fibroblasts important for wound healing.","Tissue damage activates fibroblasts from fibrocytes, which produce collagen and other ECM components, and help in wound healing. Activated fibroblasts also release cytokines and chemokines to recruit immune cells. Fibroblasts remodel the wound stroma to facilitate immune cell infiltration.","1. Fibroblasts in fibrosis: novel roles and mediators - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4034148/
2. Role of fibroblasts in wound healing and tissue remodeling on Earth ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9578548/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Tissue damage activates fibroblasts from fibrocytes, which produce collagen and other ECM components, and help in wound healing.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4034148/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9578548/']"
Fibroblast assays are currently being studied as a means of predicting how normal tissue may respond to radiation therapy in cancer patients and others.,Fibroblast assays are studied to predict normal tissue response to radiation therapy in cancer patients.,Fibroblast assays predict normal tissue response to radiation therapy. Fibroblasts avoid death and enter senescence after radiation. This helps in assessing treatment effects.,"1. Normal tissue reactions to radiotherapy - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC2670578/
2. Cancer-associated fibroblasts in radiotherapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC10173661/",Correct,The TAVILY_SUMMARY explicitly states that 'Fibroblast assays predict normal tissue response to radiation therapy' and are used to assess treatment effects. The relevant documents also support this area of study.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC2670578/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10173661/']"
"CAFs, unlike normal fibroblasts (NF), are not passive bystanders.","Cancer-associated fibroblasts (CAFs) are actively involved, unlike normal fibroblasts.","Cancer-associated fibroblasts (CAFs) actively participate in tumor growth and progression, unlike normal fibroblasts (NF), which are typically inactive. CAFs influence cancer cell behavior and the tumor microenvironment through signaling and matrix remodeling. They are essential in cancer research due to their diverse functions.","1. A framework for advancing our understanding of cancer-associated ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7046529/
2. In search of definitions: Cancer‐associated fibroblasts and their ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6972582/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Cancer-associated fibroblasts (CAFs) actively participate in tumor growth and progression, unlike normal fibroblasts (NF), which are typically inactive.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7046529/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6972582/']"
"They possess similar characteristics to myofibroblasts, the fibroblasts responsible for wound healing and chronic inflammation, such as the expression of α-smooth muscle actin (α-SMA).","CAFs share characteristics with myofibroblasts, including α-smooth muscle actin (α-SMA) expression, linked to wound healing and chronic inflammation.","Myofibroblasts express α-smooth muscle actin (α-SMA), similar to fibroblasts involved in wound healing. α-SMA is a key marker for identifying myofibroblasts. Their role in tissue repair and fibrosis is well-documented.","1. The role of α-smooth muscle actin in fibroblast-mediated matrix ... - https://pubmed.ncbi.nlm.nih.gov/27825850/
2. The Role of Myofibroblasts in Physiological and Pathological Tissue ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9808581/",Correct,"The TAVILY_SUMMARY confirms that 'Myofibroblasts express α-smooth muscle actin (α-SMA)' and are involved in wound healing. Cancer-associated fibroblasts (CAFs) are widely recognized in cancer biology to adopt a myofibroblast-like phenotype, including α-SMA expression, linking them to wound healing and chronic inflammation processes.","['https://pubmed.ncbi.nlm.nih.gov/27825850/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9808581/']"
Fibroblasts stem from a mesenchymal origin and have an elongated spindle or stellate shape with a multitude of cytoplasmic projections.,Fibroblasts originate from mesenchymal cells and have an elongated spindle/stellate shape with cytoplasmic projections.,"Fibroblasts originate from mesenchymal cells and have an elongated shape with cytoplasmic projections. They secrete extracellular matrix and signaling factors, and can transform into myofibroblasts. Their key roles include tissue repair and immune modulation.","1. Histology, Fibroblast - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK541065/
2. Fibroblasts: Origins, definitions, and functions in health and disease - https://pubmed.ncbi.nlm.nih.gov/34297930/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Fibroblasts originate from mesenchymal cells and have an elongated shape with cytoplasmic projections.'","['https://www.ncbi.nlm.nih.gov/books/NBK541065/', 'https://pubmed.ncbi.nlm.nih.gov/34297930/']"
Within the cytoplasm is an abundance of rough endoplasmic reticulum (rER) and a large Golgi apparatus.,Fibroblast cytoplasm contains abundant rough endoplasmic reticulum (rER) and a large Golgi apparatus.,"The rough endoplasmic reticulum and Golgi apparatus are located within the cytoplasm. The rough ER is involved in protein synthesis and processing, while the Golgi apparatus modifies and packages these proteins.","1. Histology, Rough Endoplasmic Reticulum - StatPearls - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK563126/
2. The Endoplasmic Reticulum - Molecular Biology of the Cell - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK26841/",Flagged for Review,The TAVILY_SUMMARY confirms the general location and function of rough endoplasmic reticulum (rER) and Golgi apparatus within the cytoplasm but does not specifically state their 'abundance' in fibroblast cytoplasm. The KNOWLEDGE_BASE_EXCERPTS contain no relevant information.,"['https://www.ncbi.nlm.nih.gov/books/NBK563126/', 'https://www.ncbi.nlm.nih.gov/books/NBK26841/']"
"CAFs can originate from the activation and differentiation of quiescent fibroblasts, bone marrow-derived mesenchymal stem cells, and epithelial and endothelial cells.","Cancer-associated fibroblasts (CAFs) originate from quiescent fibroblast activation/differentiation, bone marrow-derived mesenchymal stem cells, and epithelial/endothelial cells.","Cancer-associated fibroblasts (CAFs) originate from fibroblasts, mesenchymal stem cells, and epithelial/endothelial cells. CAFs play a role in tumor growth and metastasis. They interact with cancer cells through various mechanisms.","1. Cancer-Associated Fibroblasts: The Origin, Biological ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9497276/
2. Revisiting the role of cancer-associated fibroblasts in tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12043473/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Cancer-associated fibroblasts (CAFs) originate from fibroblasts, mesenchymal stem cells, and epithelial/endothelial cells.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9497276/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12043473/']"
The transformation from normal fibroblasts to CAFs involves complex molecular programs that reprogram their phenotype and function.,"Molecular programs reprogram normal fibroblasts to CAFs, altering their phenotype and function.",The transformation from normal fibroblasts to cancer-associated fibroblasts involves signaling pathways and metabolic reprogramming. CAFs promote cancer progression and chemoresistance. Targeting CAFs can remodel tumor microenvironment.,"1. Cancer associated fibroblasts and metabolic reprogramming - https://pmc.ncbi.nlm.nih.gov/articles/PMC11367794/
2. Targeting Cancer‐Associated Fibroblasts: Eliminate or Reprogram? - https://pmc.ncbi.nlm.nih.gov/articles/PMC11875776/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'The transformation from normal fibroblasts to cancer-associated fibroblasts involves signaling pathways and metabolic reprogramming,' which are examples of complex molecular programs that alter phenotype and function.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11367794/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11875776/']"
"As cancer progresses, the CAFs also coevolve, transitioning from an inactivated state to an activated state.","Cancer-associated fibroblasts (CAFs) coevolve with cancer progression, transitioning from inactivated to activated states.","Cancer-associated fibroblasts (CAFs) transition from inactive to active states, aiding cancer progression. CAFs secrete growth factors and cytokines, enhancing tumor growth and metastasis. Their activation is crucial for cancer cell survival and spread.","1. Cancer associated fibroblasts (CAFs) in tumor microenvironment - https://pmc.ncbi.nlm.nih.gov/articles/PMC2905156/
2. Cancer-Associated-Fibroblast-Mediated Paracrine and Autocrine ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11352219/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Cancer-associated fibroblasts (CAFs) transition from inactive to active states, aiding cancer progression.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC2905156/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11352219/']"
"A critical aspect of CAF activation involves metabolic reprogramming, particularly the phenomenon known as the \""reverse Warburg effect.\""","Metabolic reprogramming, specifically the \""reverse Warburg effect,\"" is critical for CAF activation.","CAF activation involves metabolic reprogramming, notably the reverse Warburg effect, where CAFs promote aerobic glycolysis to supply cancer cells with metabolites. This reprogramming enhances tumor growth and metastasis.","1. Cancer associated fibroblasts and metabolic reprogramming - https://pmc.ncbi.nlm.nih.gov/articles/PMC11367794/
2. Role of autophagy in cancer-associated fibroblast activation ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10791779/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'CAF activation involves metabolic reprogramming, notably the reverse Warburg effect.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11367794/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10791779/']"
"In the 1920s, Otto Warburg found that cancer cells preferably produce energy by converting glucose to lactic acid, even in aerobic conditions, to generate ATP rapidly.","Otto Warburg found that cancer cells preferentially convert glucose to lactic acid for rapid ATP generation, even aerobically.","In the 1920s, Otto Warburg discovered that cancer cells primarily produce energy through aerobic glycolysis, converting glucose to lactic acid to generate ATP rapidly. This phenomenon is known as the Warburg effect. It allows cancer cells to proliferate despite oxygen availability.","1. The Warburg Effect: How Does it Benefit Cancer Cells? - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4783224/
2. Understanding the Warburg Effect: The Metabolic Requirements of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2849637/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'In the 1920s, Otto Warburg discovered that cancer cells primarily produce energy through aerobic glycolysis, converting glucose to lactic acid to generate ATP rapidly.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4783224/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2849637/']"
"Interestingly, it was suggested that the reverse Warburg effect is the result of fibroblasts secreting lactate/pyruvate and epithelial cancer cells simultaneously taking up the energy-rich metabolites to utilize in the tricarboxylic acid (TCA) cycle.","The reverse Warburg effect involves fibroblasts secreting lactate/pyruvate, which epithelial cancer cells uptake for the TCA cycle.","The reverse Warburg effect involves fibroblasts secreting lactate/pyruvate, which cancer cells uptake to fuel their TCA cycle. This metabolic coupling supports cancer growth. Glycolytic fibroblasts promote epithelial cancer cell proliferation.","1. The reverse Warburg effect: aerobic glycolysis in cancer ... - PubMed - https://pubmed.ncbi.nlm.nih.gov/19923890/
2. Metabolic Coupling and the Reverse Warburg Effect in Cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5737780/",Correct,"The TAVILY_SUMMARY explicitly states that the reverse Warburg effect involves fibroblasts secreting lactate/pyruvate, which cancer cells then uptake to fuel their TCA cycle, directly supporting the assertion.","['https://pubmed.ncbi.nlm.nih.gov/19923890/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5737780/']"
Genetic alterations that result in the deactivation of caveolin-1 (Cav-1) expression lead to autophagy and aerobic glycolysis in cancer-associated fibroblasts.,Deactivation of caveolin-1 (Cav-1) expression in cancer-associated fibroblasts leads to autophagy and aerobic glycolysis.,Genetic alterations deactivating caveolin-1 lead to autophagy in cancer-associated fibroblasts. This results in aerobic glycolysis. Caveolin-1 deactivation is linked to metabolic reprogramming in cancer cells.,"1. Cancer associated fibroblasts in cancer development and therapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC11954198/
2. Targeting the Interplay between Cancer Metabolic Reprogramming ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8698563/",Correct,The TAVILY_SUMMARY explicitly confirms that deactivation of caveolin-1 in cancer-associated fibroblasts leads to autophagy and aerobic glycolysis.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC11954198/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8698563/']"
"Subsequently, lactate, glutamine, and other metabolites that fuel biosynthesis are synthesized and exported to initiate oxidative metabolism in neighboring cancer cells.","Cancer-associated fibroblasts synthesize and export lactate, glutamine, and other metabolites to initiate oxidative metabolism in neighboring cancer cells.","Cancer cells produce lactate and glutamine, which fuel oxidative metabolism in neighboring cancer cells. This metabolic rewiring supports cancer progression. Exosomes from the tumor microenvironment modulate this metabolic adaptation.","1. Mechanisms of Metabolic Reprogramming in Cancer Cells ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8146072/
2. Metabolites and the tumor microenvironment: from cellular ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8097259/",Flagged for Review,"The assertion states that *cancer-associated fibroblasts* synthesize and export metabolites, but the TAVILY_SUMMARY for this item indicates that *cancer cells* produce lactate and glutamine to fuel oxidative metabolism in neighboring cancer cells. This is a direct contradiction regarding the cell type responsible for production.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8146072/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8097259/']"
Fibroblasts are the most common cell type represented in connective tissue.,Fibroblasts are the most common cell type in connective tissue.,Fibroblasts are the most common cell type in connective tissue. They produce collagen and other extracellular matrix components. They play a key role in tissue repair and fibrosis.,"1. Histology, Fibroblast - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK541065/
2. Fibroblasts in fibrosis: novel roles and mediators - PubMed - https://pubmed.ncbi.nlm.nih.gov/24904424/",Correct,"The TAVILY_SUMMARY explicitly states that fibroblasts are the most common cell type in connective tissue, which is a fundamental biological fact.","['https://www.ncbi.nlm.nih.gov/books/NBK541065/', 'https://pubmed.ncbi.nlm.nih.gov/24904424/']"
"These cells produce a diverse group of products including collagen type I, III, and IV, proteoglycans, fibronectin, laminins, glycosaminoglycans, metalloproteinases, and even prostaglandins.","Fibroblasts produce collagen types I, III, IV, proteoglycans, fibronectin, laminins, glycosaminoglycans, metalloproteinases, and prostaglandins.","Fibroblasts produce collagen types I, III, and IV, proteoglycans, fibronectin, laminins, glycosaminoglycans, metalloproteinases, and prostaglandins. They are key cells in connective tissue. Their products are crucial for tissue repair and remodeling.","1. Histology, Fibroblast - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK541065/
2. Matrix Metalloproteinases, Vascular Remodeling ... - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC5765875/",Correct,"The TAVILY_SUMMARY explicitly confirms that fibroblasts produce all the listed products, including collagen types I, III, IV, proteoglycans, fibronectin, laminins, glycosaminoglycans, metalloproteinases, and prostaglandins.","['https://www.ncbi.nlm.nih.gov/books/NBK541065/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5765875/']"
"These cells synthesize reorganize the ECM found in the skin, lung, heart, kidney, liver, eye, and other organs.","Fibroblasts synthesize and reorganize extracellular matrix (ECM) in organs such as skin, lung, heart, kidney, liver, and eye.","Fibroblasts synthesize and reorganize the extracellular matrix (ECM) in various organs. They produce collagens and other ECM components. Myofibroblasts, a type of fibroblast, play a key role in wound healing.","1. Histology, Fibroblast - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK541065/
2. Remodelling the extracellular matrix in development and disease - https://pmc.ncbi.nlm.nih.gov/articles/PMC4316204/",Correct,"The TAVILY_SUMMARY confirms that fibroblasts synthesize and reorganize the extracellular matrix (ECM) in various organs, which supports the assertion that they perform this function in the listed organs.","['https://www.ncbi.nlm.nih.gov/books/NBK541065/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4316204/']"
The ECM is in constant communication with the surrounding cells as fibroblasts can secrete and respond to both autocrine and paracrine signals.,Extracellular matrix (ECM) communicates with cells via fibroblast autocrine and paracrine signaling.,"The ECM communicates with cells via fibroblast signaling, influencing cell growth and behavior. Fibroblasts use autocrine and paracrine signals. The ECM supports cell anchorage through integrin interactions.","1. Cancer-Associated-Fibroblast-Mediated Paracrine and Autocrine ... - https://pubmed.ncbi.nlm.nih.gov/39195225/
2. Biology of the Extracellular Matrix: An Overview - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4185430/",Correct,"The TAVILY_SUMMARY explicitly states that the ECM communicates with cells via fibroblast signaling, and that fibroblasts use autocrine and paracrine signals, directly supporting the assertion.","['https://pubmed.ncbi.nlm.nih.gov/39195225/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4185430/']"
"The immune system's role in cancer is complex and paradoxical, serving both tumor-suppressive and tumor-promoting functions depending on the context and activation state of different immune cell populations.","The immune system has a complex, paradoxical role in cancer, with context-dependent tumor-suppressive and tumor-promoting functions.","The immune system can both suppress and promote cancer. Cytotoxic T cells fight tumors, while tumor-associated macrophages can support tumor growth. Immune cells' roles depend on their type and activation state.","1. Roles of the immune system in cancer: from tumor initiation to ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6169832/
2. Dual Roles of Immune Cells and Their Factors in Cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3107473/",Correct,"The TAVILY_SUMMARY explicitly confirms the complex and paradoxical role of the immune system in cancer, stating it can both suppress and promote cancer, and that immune cell roles depend on their type and activation state.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6169832/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3107473/']"
"Inflammatory cells including macrophages, neutrophils, mast cells, and eosinophils are present in the TME.","Inflammatory cells like macrophages, neutrophils, mast cells, and eosinophils are present in the Tumor Microenvironment (TME).","Inflammatory cells like macrophages, neutrophils, mast cells, and eosinophils are present in the tumor microenvironment (TME). They influence tumor progression and therapy response. Mast cells particularly shape the TME by promoting angiogenesis and tumor growth.","1. Inflammation and tumor progression: signaling pathways and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8273155/
2. Role of Mast Cells in Shaping the Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7244463/",Correct,"The TAVILY_SUMMARY explicitly confirms that inflammatory cells, including macrophages, neutrophils, mast cells, and eosinophils, are present in the tumor microenvironment (TME).","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8273155/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7244463/']"
"Tumour-associated macrophages (TAMs) are prototypic inflammatory cells, playing a key role in the orchestration of the TME.",Tumour-associated macrophages (TAMs) are prototypic inflammatory cells crucial for TME orchestration.,"Tumor-associated macrophages (TAMs) play a key role in the tumor microenvironment, often polarizing to either M1 or M2 types. M1 TAMs promote anti-tumor responses, while M2 TAMs typically support tumor growth and progression. TAMs secrete various cytokines influencing immune responses.","1. The role of tumor-associated macrophages (TAMs) in tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7714989/
2. Immunity, Inflammation, and Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC2866629/",Correct,"The TAVILY_SUMMARY confirms that Tumor-associated macrophages (TAMs) play a key role in the tumor microenvironment, supporting their crucial role in TME orchestration.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7714989/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2866629/']"
Mononuclear phagocytes are extremely plastic.,Mononuclear phagocytes exhibit extreme plasticity.,"Mononuclear phagocytes are highly adaptable and can switch functions to resolve inflammation, repair tissues, and remodel during development and in response to injury. Their plasticity is crucial for tissue repair and regeneration. This adaptability is a key feature of their role in healing and immune response.","1. Macrophage plasticity and polarization in tissue repair ... - PubMed - https://pubmed.ncbi.nlm.nih.gov/23096265/
2. Diversity and plasticity of mononuclear phagocytes - PubMed - https://pubmed.ncbi.nlm.nih.gov/21952798/",Correct,"The TAVILY_SUMMARY explicitly states that mononuclear phagocytes are 'highly adaptable' and their 'plasticity is crucial' for various functions, directly supporting the assertion.","['https://pubmed.ncbi.nlm.nih.gov/23096265/', 'https://pubmed.ncbi.nlm.nih.gov/21952798/']"
"In the context of interferon-driven type 1 immune responses, macrophages acquire tumoricidal activity.",Macrophages acquire tumoricidal activity during interferon-driven type 1 immune responses.,Macrophages gain tumoricidal activity through interferon-driven type 1 immune responses. This transformation enhances their ability to kill cancer cells. This process is part of the innate immune system's response to tumors.,"1. Immune function - World Cancer Report - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK606527/
2. Macrophages in immunoregulation and therapeutics - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC10200802/",Correct,"The TAVILY_SUMMARY confirms that 'Macrophages gain tumoricidal activity through interferon-driven type 1 immune responses,' which enhances their ability to kill cancer cells.","['https://www.ncbi.nlm.nih.gov/books/NBK606527/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10200802/']"
"However, in the tumor microenvironment, macrophages often adopt a phenotype that promotes rather than inhibits tumor growth.",Macrophages in the tumor microenvironment often adopt a tumor-promoting phenotype.,"Macrophages in the tumor microenvironment often adopt an M2 phenotype that promotes tumor growth and angiogenesis. These M2 macrophages have low tumoricidal activity and create a favorable environment for tumor survival. In late-stage tumors, M2 macrophages dominate and support tumor progression.","1. Tumor-Associated Macrophages as Major Players in the Tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4190561/
2. Tumor-Associated Macrophages and Their Functional ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8481680/",Correct,"The TAVILY_SUMMARY states that 'Macrophages in the tumor microenvironment often adopt an M2 phenotype that promotes tumor growth and angiogenesis,' directly supporting the assertion of a tumor-promoting phenotype.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4190561/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8481680/']"
"Several studies indicate that tumor-associated macrophages (TAMs) usually have a pro-tumoral action, since they can stimulate angiogenesis, increase tumor cell invasion and motility, and have an immunosuppressive action.","Tumor-associated macrophages (TAMs) exert pro-tumoral actions, including stimulating angiogenesis, increasing tumor cell invasion/motility, and immunosuppression.","Tumor-associated macrophages (TAMs) typically promote tumor growth by stimulating angiogenesis and invasion, and have immunosuppressive effects. Some studies suggest that reprogramming TAMs can enhance anti-tumor immune responses. CSF1/CSF1R blockade can reprogram TAMs to improve immunotherapy outcomes.","1. Tumor-Associated Macrophages as Major Immunosuppressive Cells ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11475569/
2. The role of tumor-associated macrophages (TAMs) in tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7714989/",Correct,"The TAVILY_SUMMARY explicitly confirms that 'Tumor-associated macrophages (TAMs) typically promote tumor growth by stimulating angiogenesis and invasion, and have immunosuppressive effects,' aligning with the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11475569/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7714989/']"
"That is, the image was obtained without any fluorophores, stains, or dyes, using only the metabolic co-factors of NADH and FAD, which are already inside of cells, along with second harmonic generation to see collagen.","Label-free imaging technique utilizes metabolic co-factors NADH and FAD, and second harmonic generation to visualize collagen without fluorophores or dyes.",The image uses NADH and FAD co-factors and second harmonic generation for collagen. It avoids external stains and relies on intrinsic cellular components. This method provides detailed metabolic and structural cellular information.,"1. Second harmonic generation microscopy: a powerful tool for bio ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9995455/
2. Evaluating Cell Metabolism Through Autofluorescence Imaging of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6352511/",Correct,"The TAVILY_SUMMARY confirms that the imaging technique uses 'NADH and FAD co-factors and second harmonic generation for collagen' and 'avoids external stains and relies on intrinsic cellular components,' matching the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9995455/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6352511/']"
"The phenotype of tumour-associated macrophages is shifted to a pro-fibrotic, pro-angiogenic phenotype, M2, characterized by production of arginase, IL-10, and TGF-β as well as IL-23.","Tumour-associated macrophages (TAMs) exhibit an M2 phenotype, characterized by pro-fibrotic, pro-angiogenic properties and production of arginase, IL-10, TGF-β, and IL-23.","Tumor-associated macrophages exhibit a pro-fibrotic, pro-angiogenic M2 phenotype, producing arginase, IL-10, TGF-β, and IL-23. These macrophages support tumor growth and progression. Their shift to M2 is often driven by hypoxia.","1. Understanding the Mysterious M2 Macrophage through Activation ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4452191/
2. Tumor-Associated Macrophages and Their Functional ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8481680/",Correct,"The TAVILY_SUMMARY directly states that 'Tumor-associated macrophages exhibit a pro-fibrotic, pro-angiogenic M2 phenotype, producing arginase, IL-10, TGF-β, and IL-23,' confirming all aspects of the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4452191/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8481680/']"
"IL-4 and IL-13 produced by Th2 cells or by eosinophils elicit alternative M2 polarization of macrophages, which results in tumour promotion.","IL-4 and IL-13 from Th2 cells or eosinophils induce M2 macrophage polarization, promoting tumor growth.","IL-4 and IL-13 promote M2 macrophage polarization, aiding tumor promotion. Th2 cells and eosinophils are primary sources of these cytokines. M2 macrophages support tumor growth.","1. Understanding the Mysterious M2 Macrophage through Activation ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4452191/
2. Pro-inflammatory polarization primes Macrophages to transition into ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9272532/",Correct,"The TAVILY_SUMMARY confirms that 'IL-4 and IL-13 promote M2 macrophage polarization, aiding tumor promotion' and that 'Th2 cells and eosinophils are primary sources of these cytokines,' supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4452191/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9272532/']"
Evidence suggests that this pathway plays a dominant role in carcinoma of the breast and in pancreatic ductal adenocarcinoma.,The M2 macrophage polarization pathway plays a dominant role in breast carcinoma and pancreatic ductal adenocarcinoma.,The PI3K/AKT/mTOR pathway plays a dominant role in breast carcinoma and pancreatic ductal adenocarcinoma. KRAS mutations are critical in these cancers. Targeted therapies are being developed to address these pathways.,"1. Molecular mechanism of pancreatic ductal adenocarcinoma - https://pmc.ncbi.nlm.nih.gov/articles/PMC11686552/
2. Oncogenic signaling pathways in pancreatic ductal adenocarcinoma - https://pubmed.ncbi.nlm.nih.gov/37268398/",Incorrect,"The TAVILY_SUMMARY states that the 'PI3K/AKT/mTOR pathway' plays a dominant role in breast carcinoma and pancreatic ductal adenocarcinoma, not the M2 macrophage polarization pathway as asserted.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11686552/', 'https://pubmed.ncbi.nlm.nih.gov/37268398/']"
"The immune system's antitumor activity is mainly carried out by tumor antigen-specific cytotoxic T lymphocytes (CTL), T effector (Teff) cells, antibody-producing B cells, as well as antigen-presenting dendritic cells (DC), which lead to adaptive immunity by directly recognizing and eliminating cancer cells.","Antitumor adaptive immunity is primarily mediated by tumor antigen-specific cytotoxic T lymphocytes (CTL), T effector (Teff) cells, antibody-producing B cells, and antigen-presenting dendritic cells (DC).","The immune system's antitumor activity is mainly by tumor-specific cytotoxic T cells, T effector cells, B cells, and dendritic cells. These components lead to adaptive immunity by eliminating cancer cells.","1. Role of T cells in cancer immunotherapy - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC10846312/
2. Update on Dendritic Cell-Induced Immunological and Clinical ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5715373/",Correct,"The TAVILY_SUMMARY confirms that 'The immune system's antitumor activity is mainly by tumor-specific cytotoxic T cells, T effector cells, B cells, and dendritic cells,' which lead to adaptive immunity.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10846312/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5715373/']"
"Whereas a Th1-orchestrated cytotoxic T-cell-mediated response has a protective function, Th2-polarized T cells and Th17 cells trigger tumour-promoting cascades.","Th1-orchestrated cytotoxic T-cell responses are protective, while Th2-polarized T cells and Th17 cells trigger tumor-promoting cascades.","Th1 responses protect against tumors, while Th2 and Th17 responses promote tumor growth. This balance is crucial in cancer development.","1. Immune function - World Cancer Report - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK606527/
2. Polarized immune responses differentially regulate cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2494984/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Th1 responses protect against tumors, while Th2 and Th17 responses promote tumor growth.'","['https://www.ncbi.nlm.nih.gov/books/NBK606527/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2494984/']"
"Even though this defense system is well developed, the tumor often has the ability to develop an immunosuppressive microenvironment favorable to its progression.",Tumors can develop an immunosuppressive microenvironment that favors tumor progression despite a developed immune defense system.,"Despite advanced defense systems, tumors often create an immunosuppressive environment, hindering immune response and promoting progression. This environment includes inhibitory immune cells and metabolic changes that suppress immune activity.","1. Role of tumor microenvironment in cancer progression and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10242329/
2. Editorial: The immunosuppressive tumor microenvironment and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10332107/",Correct,"The TAVILY_SUMMARY explicitly states that tumors can create an immunosuppressive environment despite advanced defense systems, which hinders immune response and promotes progression. The relevant document titles also support this concept.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10242329/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10332107/']"
"Specifically, myeloid-derived suppressor cells (MDSC), regulatory T (Treg) cells, and tumor-associated macrophages (TAMs) are well-known players.","Myeloid-derived suppressor cells (MDSC), regulatory T (Treg) cells, and tumor-associated macrophages (TAMs) contribute to immunosuppression in tumors.","Myeloid-derived suppressor cells, regulatory T cells, and tumor-associated macrophages play roles in suppressing immune responses and promoting tumor growth. Tumor-associated macrophages can switch between M1 and M2 types, complicating their targeting. MDSCs contribute to tumor progression through oxidative metabolism.","1. The nature of myeloid-derived suppressor cells in the tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4775398/
2. The role of tumor-associated macrophages (TAMs) in tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7714989/",Correct,"The TAVILY_SUMMARY explicitly states that Myeloid-derived suppressor cells (MDSC), regulatory T (Treg) cells, and tumor-associated macrophages (TAMs) play roles in suppressing immune responses and promoting tumor growth, directly supporting their contribution to immunosuppression in tumors.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4775398/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7714989/']"
"Tumour progression and escape are associated with immunosuppressive pathways in innate and adaptive anti-tumour responses, which include, among others, suppressive myeloid cells, activation of checkpoint blockade, and induction and recruitment of Treg cells.","Tumour progression and escape are linked to immunosuppressive pathways involving suppressive myeloid cells, checkpoint blockade, and Treg cell induction/recruitment.","Tumour progression and escape involve immunosuppressive pathways, including suppressive myeloid cells and checkpoint blockade activation. Treg cells are recruited to inhibit anti-tumour responses. Targeting these pathways can enhance anti-tumour immunity.","1. Immune function - World Cancer Report - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK606527/
2. Progression of the Immune Escape Mechanism in Tumors - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC11591798/",Correct,"The TAVILY_SUMMARY confirms that tumor progression and escape involve immunosuppressive pathways, specifically mentioning suppressive myeloid cells, checkpoint blockade activation, and Treg cell recruitment to inhibit anti-tumour responses.","['https://www.ncbi.nlm.nih.gov/books/NBK606527/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11591798/']"
Endothelial cells form the inner lining of blood vessels and play a crucial role in tumor angiogenesis—the formation of new blood vessels that supply nutrients and oxygen to growing tumors.,"Endothelial cells form blood vessel lining and play a crucial role in tumor angiogenesis, supplying nutrients and oxygen to tumors.",Endothelial cells line blood vessels and are key in tumor angiogenesis. They form new blood vessels supplying tumors with nutrients and oxygen. This process involves endothelial cell proliferation and migration.,"1. Overview of Angiogenesis - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK53238/
2. Inducing Angiogenesis, a Key Step in Cancer Vascularization, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7281705/",Correct,"The TAVILY_SUMMARY explicitly states that endothelial cells line blood vessels and are key in tumor angiogenesis, forming new blood vessels that supply tumors with nutrients and oxygen.","['https://www.ncbi.nlm.nih.gov/books/NBK53238/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7281705/']"
"Angiogenesis, the growth of new capillary blood vessels, is central to the growth of cancer.","Angiogenesis, the growth of new capillary blood vessels, is central to cancer growth.",Angiogenesis is essential for cancer growth and metastasis. Tumor cells secrete factors like VEGF to stimulate new blood vessel formation. Anti-angiogenesis therapies aim to inhibit this process to stop tumor growth.,"1. Angiogenesis and targeted therapy in the tumour microenvironment - https://pmc.ncbi.nlm.nih.gov/articles/PMC12017902/
2. Overview on the Different Patterns of Tumor Vascularization - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8000806/",Correct,"The TAVILY_SUMMARY explicitly states that angiogenesis is essential for cancer growth and metastasis. Additionally, the KNOWLEDGE_BASE_EXCERPTS mention that nicotine can increase angiogenesis, implying its importance in cancer proliferation.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC12017902/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8000806/']"
"Because the oxygen diffusion distance is 100 to 200 microns, tumor cells that exceed these distances from a capillary vessel become anoxic.","Tumor cells become anoxic if they exceed 100-200 microns from a capillary vessel, due to oxygen diffusion limits.",Tumor cells beyond 100 to 200 microns from a capillary vessel become anoxic due to the limited oxygen diffusion distance. Chronic hypoxia occurs when cells are too far from blood vessels. Therapeutic strategies aim to deliver oxygen directly to hypoxic areas.,"1. Measurement of oxygen diffusion distance in tumor cubes ... - PubMed - https://pubmed.ncbi.nlm.nih.gov/1735668/
2. Hypoxia and the Tumor Microenvironment - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC8358492/",Correct,The TAVILY_SUMMARY explicitly states that tumor cells beyond 100 to 200 microns from a capillary vessel become anoxic due to the limited oxygen diffusion distance.,"['https://pubmed.ncbi.nlm.nih.gov/1735668/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8358492/']"
"Vascular casts of metastases in the rabbit liver reveal that tumors of up to 1 mm in diameter are usually avascular, but beyond that size are vascularized.","Rabbit liver metastases reveal tumors up to 1 mm are avascular, but larger tumors are vascularized.",Tumors up to 1 mm in diameter are usually avascular; larger tumors become vascularized. The main feeding artery for tumors is around 0.7 mm. Tumors in rabbits are mainly vascularized by the hepatic artery.,"1. Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9128410/
2. Overview on the Different Patterns of Tumor Vascularization - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8000806/",Correct,"The TAVILY_SUMMARY explicitly states that tumors up to 1 mm in diameter are usually avascular, while larger tumors become vascularized, and mentions this in the context of rabbit tumors.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9128410/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8000806/']"
"This size limitation necessitates the \""angiogenic switch\"" for continued tumor growth.","The tumor size limitation requires an \""angiogenic switch\"" for sustained tumor growth.","Tumor growth beyond a certain size requires the ""angiogenic switch"" to create new blood vessels. This switch involves sprouting angiogenesis and vessel co-option. It enables tumors to obtain necessary oxygen and nutrients.","1. Inducing Angiogenesis, a Key Step in Cancer Vascularization, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7281705/
2. Decoding tumor angiogenesis: pathways, mechanisms, and future ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12007322/",Correct,"The TAVILY_SUMMARY explicitly states that tumor growth beyond a certain size requires the 'angiogenic switch' to create new blood vessels, enabling sustained tumor growth.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7281705/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12007322/']"
Step 1 (hypoxia): the hypoxic or inflamed tumor microenvironment (TME) induces the production of vasculogenetic growth factors.,Tumor angiogenesis step 1: Hypoxic or inflamed TME induces vasculogenetic growth factor production.,"The hypoxic or inflamed tumor microenvironment induces the production of vasculogenetic growth factors, primarily vascular endothelial growth factor (VEGF). These factors promote angiogenesis, aiding tumor growth and metastasis. This process is critical in cancer progression.","1. Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10487419/
2. DPSCs-ECs Communication via FN1-ITGA5 Signaling - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC11087358/",Correct,"The TAVILY_SUMMARY explicitly states that the hypoxic or inflamed tumor microenvironment induces the production of vasculogenetic growth factors, such as vascular endothelial growth factor (VEGF).","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10487419/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11087358/']"
"Step 2 (proteolytic degradation): VEGF-A and -D binding to VEGFR-2 induce the production of matrix metalloproteinases (MMPs), degrading the extracellular matrix (ECM).",Tumor angiogenesis step 2: VEGF-A and -D binding to VEGFR-2 induces MMP production and ECM degradation.,"VEGF-A and -D binding to VEGFR-2 triggers MMP production, which degrades the extracellular matrix. MMPs facilitate tissue remodeling. This process is crucial for angiogenesis.","1. The Roles of Matrix Metalloproteinases and Their Inhibitors in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7767220/
2. The influence of vascular endothelial growth factor-A and matrix ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5614795/",Correct,"The TAVILY_SUMMARY explicitly states that VEGF-A and -D binding to VEGFR-2 triggers the production of matrix metalloproteinases (MMPs), which then degrade the extracellular matrix (ECM).","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7767220/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5614795/']"
Step 3 (tip cell migration): VEGFR-2 activation induces the transformation of ECs to tip cells (brown).,Tumor angiogenesis step 3: VEGFR-2 activation transforms endothelial cells (ECs) into tip cells.,VEGFR-2 activation transforms endothelial cells into tip cells. This triggers downstream signaling pathways like MAPK and PI3K. Tip cells lead the formation of new blood vessels.,"1. The role of VEGF receptors in angiogenesis; complex partnerships - https://pmc.ncbi.nlm.nih.gov/articles/PMC2773843/
2. VEGF-A/VEGFR2 signaling network in endothelial cells relevant to ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5143324/",Correct,"The TAVILY_SUMMARY explicitly states that VEGFR-2 activation transforms endothelial cells into tip cells, which lead new blood vessel formation. The RELEVANT_DOCS_LIST also points to sources discussing the role of VEGF receptors and VEGFR2 signaling in angiogenesis. The KNOWLEDGE_BASE_EXCERPTS are not relevant to this specific assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC2773843/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5143324/']"
"Step 4 (tube formation): tip cells migrate into the TME with coordinated proliferation of stalk cells, forming a new tube.",Tumor angiogenesis step 4: Tip cells migrate into the TME with stalk cell proliferation to form new vessel tubes.,"Tip cells lead sprout formation, while stalk cells proliferate to form new tubes. Tip cells migrate, and stalk cells support elongation and stability. Together, they create new vascular connections.","1. VEGF and Notch in Tip and Stalk Cell Selection - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3530037/
2. Techniques and assays for the study of angiogenesis - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4216737/",Correct,"The TAVILY_SUMMARY confirms that tip cells lead sprout formation and migrate, while stalk cells proliferate to form new tubes, supporting the assertion. The RELEVANT_DOCS_LIST includes a document specifically on 'VEGF and Notch in Tip and Stalk Cell Selection'. The KNOWLEDGE_BASE_EXCERPTS are not relevant to this specific assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3530037/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4216737/']"
Step 5 (tumor vascularization): the new vessels mature by establishing tight junctions and by the coverage by pericytes (lila).,Tumor angiogenesis step 5: New vessels mature by forming tight junctions and acquiring pericyte coverage.,Tumor vascularization involves new vessel maturation through tight junctions and pericyte coverage. Pericytes stabilize vessels and support maturation. This process is crucial for tumor growth and progression.,"1. The role of pericytes in blood-vessel formation and maintenance - https://pmc.ncbi.nlm.nih.gov/articles/PMC1871727/
2. Overview on the Different Patterns of Tumor Vascularization - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8000806/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that tumor vascularization involves new vessel maturation through tight junctions and pericyte coverage, with pericytes stabilizing vessels. The RELEVANT_DOCS_LIST includes a document on 'The role of pericytes in blood-vessel formation and maintenance'. The KNOWLEDGE_BASE_EXCERPTS are not relevant to this specific assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC1871727/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8000806/']"
"VEGF-A (Vascular Endothelial Growth Factor-A) expression is greatly stimulated by tissue hypoxia and, perhaps independently, by low tissue pH, conditions that are commonly present in the tumor microenvironment.","VEGF-A expression is stimulated by tissue hypoxia and low tissue pH, common conditions in the tumor microenvironment.","VEGF-A expression is significantly stimulated by tissue hypoxia and low pH, conditions prevalent in the tumor microenvironment. This upregulation is crucial for tumor angiogenesis. VEGF-A is mainly produced by tumor and stromal cells.","1. Association between pH regulation of the tumor microenvironment ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10363976/
2. Vascular Endothelial growth factor signaling in hypoxia and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4048289/",Correct,"The TAVILY_SUMMARY explicitly states that VEGF-A expression is significantly stimulated by tissue hypoxia and low pH, conditions prevalent in the tumor microenvironment. The RELEVANT_DOCS_LIST provides sources directly linking pH regulation and VEGF signaling in hypoxia to the tumor microenvironment. The KNOWLEDGE_BASE_EXCERPTS are not relevant to this specific assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10363976/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4048289/']"
"VEGF-A action induces endothelial cells to express increased amounts of tissue factor, urokinase, tissue plasminogen activator and matrix metalloproteases.","VEGF-A induces endothelial cells to express increased tissue factor, urokinase, tissue plasminogen activator, and matrix metalloproteases.","VEGF-A stimulates endothelial cells to increase tissue factor, urokinase, tissue plasminogen activator, and matrix metalloproteases. These factors promote angiogenesis and ECM remodeling. VEGF-A acts via VEGFR-2 to enhance proteolytic activity.","1. Mechanism and its regulation of tumor-induced angiogenesis - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4611774/
2. VEGF-initiated angiogenesis and the uPA/uPAR system - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3547900/",Correct,"The TAVILY_SUMMARY confirms that VEGF-A stimulates endothelial cells to increase the expression of tissue factor, urokinase, tissue plasminogen activator, and matrix metalloproteases, which promote angiogenesis and ECM remodeling. The RELEVANT_DOCS_LIST includes a document on 'VEGF-initiated angiogenesis and the uPA/uPAR system', directly supporting the role of urokinase and plasminogen activator. The KNOWLEDGE_BASE_EXCERPTS are not relevant to this specific assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4611774/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3547900/']"
"Collectively, these endothelial cell products induce clotting and initiate fibrinolysis and degradation of collagen and other elements of preexisting matrix, all-important steps in angiogenesis and stroma generation.","Endothelial cell products induce clotting, fibrinolysis, and degradation of collagen and matrix elements, crucial for angiogenesis and stroma generation.","Endothelial cells release products that promote clotting, fibrinolysis, and matrix degradation, crucial for angiogenesis and stroma formation. These processes involve ECM remodeling and cell signaling. Key factors include angiopoietin-1, PlGF, and TGF-β.","1. The Role of Stromal Myofibroblast and Extracellular Matrix in Tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3411128/
2. Multiple Functions of the Endothelial Cells - The Endothelium - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK57148/",Correct,"The TAVILY_SUMMARY states that endothelial cells release products that promote clotting, fibrinolysis, and matrix degradation, which are crucial for angiogenesis and stroma formation. The RELEVANT_DOCS_LIST includes a document on 'Multiple Functions of the Endothelial Cells - The Endothelium'. The KNOWLEDGE_BASE_EXCERPTS are not relevant to this specific assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3411128/', 'https://www.ncbi.nlm.nih.gov/books/NBK57148/']"
"A microscopic population of angiogenic tumor cells will begin to modify microvessels in the neighborhood by inducing an increase in vascular permeability, dilation, and tortuosity even before the induction of new vascular sprouts.","Angiogenic tumor cells modify microvessels, increasing vascular permeability, dilation, and tortuosity before new vascular sprout induction.","Angiogenic tumor cells modify microvessels by increasing permeability, dilation, and tortuosity before new sprouts form. This process alters the vascular structure significantly. These changes precede the growth of new blood vessels.","1. Beginning of angiogenesis research - Holland-Frei Cancer Medicine - https://www.ncbi.nlm.nih.gov/books/NBK13877/
2. NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3258432/",Correct,"The TAVILY_SUMMARY directly supports the assertion, indicating that angiogenic tumor cells modify microvessels by increasing permeability, dilation, and tortuosity before new sprouts form. The RELEVANT_DOCS_LIST includes documents related to angiogenesis research and vascular normalization. The KNOWLEDGE_BASE_EXCERPTS are not relevant to this specific assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK13877/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3258432/']"
"The relationship between cancer cells and stromal components is bidirectional and dynamic, with both compartments influencing each other's behavior and function through complex molecular crosstalk.","Cancer cells and stromal components have a bidirectional, dynamic relationship, influencing each other via complex molecular crosstalk.","Cancer cells and stromal components interact bidirectionally, influencing each other's behavior through signaling pathways and molecular crosstalk. This interaction affects cancer cell survival, proliferation, and resistance to apoptosis. Key factors include cytokines, growth factors, and signaling cascades like MEK/p42/p44/MAPK.","1. Cancer-stromal interactions: Role in cell survival, metabolism and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3230306/
2. The Give-and-Take Interaction Between the Tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9043524/",Correct,"The TAVILY_SUMMARY explicitly states that cancer cells and stromal components interact bidirectionally, influencing each other's behavior through signaling pathways and molecular crosstalk. The RELEVANT_DOCS_LIST includes documents directly addressing 'Cancer-stromal interactions' and 'The Give-and-Take Interaction Between the Tumor'. The KNOWLEDGE_BASE_EXCERPTS are not relevant to this specific assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3230306/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9043524/']"
"As shown here, lung cancer is associated with a vast stromal desmoplastic reaction (the \""neighborhood\"") in which the connective tissue, associated with the tumor, thickens similarly to scars.","Lung cancer is associated with extensive stromal desmoplastic reaction, causing connective tissue thickening similar to scars.","Lung cancer is associated with a desmoplastic reaction, where connective tissue thickens around the tumor, forming scar-like tissue. This reaction limits chemotherapy effectiveness due to dense scar tissue. Desmoplastic reaction helps contain cancer spread but complicates treatment.","1. Multifaced roles of desmoplastic reaction and fibrosis in pancreatic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10475783/
2. Desmoplastic reaction in the microenvironment of head and neck ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11806477/",Correct,"The TAVILY_SUMMARY confirms that lung cancer is associated with a desmoplastic reaction, where connective tissue thickens around the tumor, forming scar-like tissue. The RELEVANT_DOCS_LIST includes documents discussing 'desmoplastic reaction' in the context of cancer. The KNOWLEDGE_BASE_EXCERPTS are not relevant to this specific assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10475783/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11806477/']"
Accumulating evidence indicates that the epithelial and stromal compartments interact to enhance the aggressive nature of this disease.,Epithelial and stromal compartments interact to enhance the aggressiveness of cancer.,"Epithelial and stromal compartments interact to enhance disease aggressiveness. This interaction disrupts normal tissue development, promoting cancer progression. Stromal changes support tumor growth and invasion.","1. Perspectives on Tissue Interactions in Development and Disease - https://pmc.ncbi.nlm.nih.gov/articles/PMC4195241/
2. Distinct Transcriptional Changes and Epithelial-stromal Interactions ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5025366/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that epithelial and stromal compartments interact to enhance disease aggressiveness and promote cancer progression. The RELEVANT_DOCS_LIST includes documents on 'Tissue Interactions in Development and Disease' and 'Epithelial-stromal Interactions'. The KNOWLEDGE_BASE_EXCERPTS explicitly state 'No relevant information found in knowledge base' for this item.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4195241/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5025366/']"
Pancreatic cancer cells release various factors that stimulate the stroma.,Pancreatic cancer cells release factors that stimulate the tumor stroma.,"Pancreatic cancer cells release factors like CCL2, HGF, and FGF that stimulate cancer-associated fibroblasts (CAFs) in the stroma. These CAFs promote desmoplasia and secrete collagen and other proteins. CAFs also attract immune cells and contribute to tumor progression.","1. Role of the tumor microenvironment in pancreatic cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6422798/
2. The Role of Stroma in Tumor Development - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4963227/",Correct,"The TAVILY_SUMMARY explicitly states that 'Pancreatic cancer cells release factors like CCL2, HGF, and FGF that stimulate cancer-associated fibroblasts (CAFs) in the stroma,' directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6422798/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4963227/']"
"Stromal cells, in turn, release mitogenic substances that stimulate tumor growth, invasion, and resistance to therapy.","Stromal cells release mitogenic substances that stimulate tumor growth, invasion, and therapy resistance.","Stromal cells release mitogenic substances that promote tumor growth, invasion, and resistance to therapy. These factors often involve complex signaling pathways and interactions with cancer cells. Targeting these pathways can help inhibit tumor progression.","1. Antimitotic drugs in the treatment of cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4648954/
2. Cisplatin based therapy: the role of the mitogen activated protein ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5896132/",Correct,"The TAVILY_SUMMARY confirms that 'Stromal cells release mitogenic substances that promote tumor growth, invasion, and resistance to therapy,' which aligns with the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4648954/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5896132/']"
"Stroma production is stimulated by cancer-cell derived growth factors including transforming growth factor-β (TGFβ), hepatocyte growth factor (HGF), fibroblast growth factor (FGF), insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF).","Cancer cell-derived growth factors (TGFβ, HGF, FGF, IGF-1, EGF) stimulate stroma production.","Stroma production in cancer is stimulated by growth factors like TGFβ, HGF, FGF, IGF-1, and EGF. These factors activate signaling pathways that influence cancer-associated fibroblasts. These fibroblasts remodel the tumor microenvironment.","1. Roles for Growth Factors in Cancer Progression - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3062054/
2. Signaling pathways in cancer‐associated fibroblasts - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC9859735/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Stroma production in cancer is stimulated by growth factors like TGFβ, HGF, FGF, IGF-1, and EGF.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3062054/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9859735/']"
Recent studies have demonstrated that Shh exerts its effect principally through a paracrine pathway in PDAC.,Shh acts via a paracrine pathway in pancreatic ductal adenocarcinoma (PDAC).,Shh primarily acts through a paracrine pathway in pancreatic ductal adenocarcinoma (PDAC). The Hedgehog pathway is activated in most pancreatic cancer cases. Research emphasizes its role in the tumor microenvironment.,"1. Sonic Hedgehog in pancreatic cancer: From bench to bedside, then ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3806061/
2. Pancreatic Cancer and Hedgehog Pathway Signaling: New Insights - https://pmc.ncbi.nlm.nih.gov/articles/PMC7075422/",Correct,"The TAVILY_SUMMARY explicitly confirms that 'Shh primarily acts through a paracrine pathway in pancreatic ductal adenocarcinoma (PDAC),' directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3806061/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7075422/']"
These experiments have shown that Shh produced by tumor cells plays a key role in the recruitment and maintenance of the tumor mesenchyme.,Tumor cell-produced Shh is key for recruiting and maintaining tumor mesenchyme.,Shh from tumor cells recruits and maintains tumor mesenchyme. It activates the HH signaling pathway in surrounding stroma. Inhibition of Shh reduces tumor growth and proliferation.,"1. Hedgehog signaling in tissue homeostasis, cancers and targeted ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10439210/
2. Sonic hedgehog signalling pathway in CNS tumours - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC11580395/",Correct,"The TAVILY_SUMMARY states that 'Shh from tumor cells recruits and maintains tumor mesenchyme,' which directly supports the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10439210/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11580395/']"
Global gene expression analysis of genes differentially expressed in fibroblasts cultured in the absence or presence of pancreatic cancer cell lines revealed 43 up-regulated and 31 down-regulated transcripts.,Gene expression analysis reveals 43 up-regulated and 31 down-regulated transcripts in fibroblasts co-cultured with pancreatic cancer cells.,Global gene expression analysis found 43 up-regulated and 31 down-regulated transcripts in fibroblasts cultured with pancreatic cancer cells. This study used cDNA microarrays and Affymetrix exon arrays. The results showed significant differences in gene expression between cancer-associated fibroblasts and control fibroblasts.,"1. Exploration of Global Gene Expression Patterns in Pancreatic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC1851213/
2. Unlike pancreatic cancer cells pancreatic cancer associated ... - https://pubmed.ncbi.nlm.nih.gov/22984426/",Correct,The TAVILY_SUMMARY directly confirms the assertion: 'Global gene expression analysis found 43 up-regulated and 31 down-regulated transcripts in fibroblasts cultured with pancreatic cancer cells.',"['https://pmc.ncbi.nlm.nih.gov/articles/PMC1851213/', 'https://pubmed.ncbi.nlm.nih.gov/22984426/']"
"Among the most highly up-regulated genes were members of the CXC/CC chemokine family including MCP-1 (CCL2), interleukin-(IL)-8 (CXCL8), GRO1 (CXCL1), and GRO2 (CXCL2); all of which have been implicated in tumor invasion and angiogenesis.","Highly up-regulated genes (MCP-1, IL-8, GRO1, GRO2) in fibroblasts are CXC/CC chemokines implicated in tumor invasion and angiogenesis.","CXC/CC chemokines like MCP-1, IL-8, GRO1, and GRO2 are highly up-regulated, promoting tumor invasion and angiogenesis. These chemokines are linked to cancer progression and metastasis. Their roles in inflammation and immune response are well-documented.","1. The Role of CXC Chemokines in Cancer Progression - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9818145/
2. New genetic and epigenetic insights into the chemokine system - https://pmc.ncbi.nlm.nih.gov/articles/PMC10189238/",Correct,"The TAVILY_SUMMARY explicitly states that 'CXC/CC chemokines like MCP-1, IL-8, GRO1, and GRO2 are highly up-regulated, promoting tumor invasion and angiogenesis,' directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9818145/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10189238/']"
"The metabolic interaction between cancer cells and stromal components represents a crucial aspect of tumor-stroma relationships, with important implications for tumor growth and therapeutic resistance.",Metabolic interaction between cancer cells and stromal components is crucial for tumor growth and therapeutic resistance.,Cancer cells interact with stromal components to enhance growth and resistance through metabolic pathways. Tumor microenvironment influences immune cell metabolism. Hypoxic regions promote anaerobic glycolysis in cancer cells.,"1. Metabolic Interactions in the Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5814137/
2. Cancer-stromal interactions: Role in cell survival, metabolism and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3230306/",Correct,"The TAVILY_SUMMARY confirms that 'Cancer cells interact with stromal components to enhance growth and resistance through metabolic pathways,' which supports the assertion about the crucial role of metabolic interaction for tumor growth and therapeutic resistance.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5814137/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3230306/']"
Cancer-associated fibroblasts undergo the reverse Warburg effect and provide cancer cells with glycolytic metabolites.,"Cancer-associated fibroblasts (CAFs) undergo the reverse Warburg effect, supplying glycolytic metabolites to cancer cells.","Cancer-associated fibroblasts undergo the reverse Warburg effect, producing glycolytic metabolites that support cancer cells. This process involves aerobic glycolysis in fibroblasts, providing lactate and pyruvate to cancer cells. This metabolic coupling is crucial for tumor growth.","1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. The reverse Warburg effect: aerobic glycolysis in cancer ... - PubMed - https://pubmed.ncbi.nlm.nih.gov/19923890/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Cancer-associated fibroblasts undergo the reverse Warburg effect, producing glycolytic metabolites that support cancer cells.'","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pubmed.ncbi.nlm.nih.gov/19923890/']"
This metabolic reprogramming allows for efficient energy utilization within the tumor microenvironment.,Metabolic reprogramming in the tumor microenvironment enables efficient energy utilization.,"Metabolic reprogramming enables tumor cells to efficiently utilize energy, primarily through glycolysis, to thrive in the tumor microenvironment. This adaptation supports growth and metastasis. Lipid metabolic reprogramming also influences the immune response within the tumor microenvironment.","1. The role of lipid metabolic reprogramming in tumor microenvironment - https://pmc.ncbi.nlm.nih.gov/articles/PMC10091885/
2. Metabolic reprogramming in tumor immune microenvironment - https://pubmed.ncbi.nlm.nih.gov/38906524/",Correct,"The TAVILY_SUMMARY confirms that 'Metabolic reprogramming enables tumor cells to efficiently utilize energy, primarily through glycolysis, to thrive in the tumor microenvironment,' directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10091885/', 'https://pubmed.ncbi.nlm.nih.gov/38906524/']"
CAF-derived lactate is crucial in prostate cancer metabolic transformation towards OXPHOS.,CAF-derived lactate is crucial for prostate cancer metabolic transformation towards OXPHOS.,CAF-derived lactate is crucial for prostate cancer's shift to oxidative phosphorylation (OXPHOS). It enhances cancer cell invasiveness and modulates the immune response. This lactate uptake promotes tumor growth and metastasis.,"1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Lactate as Key Metabolite in Prostate Cancer Progression - https://pmc.ncbi.nlm.nih.gov/articles/PMC10340474/",Correct,"The TAVILY_SUMMARY explicitly states that CAF-derived lactate is crucial for prostate cancer's metabolic shift towards oxidative phosphorylation (OXPHOS), promoting tumor growth and metastasis.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10340474/']"
CAFs can transfer functional mitochondria to prostate cancer cells.,Cancer-associated fibroblasts (CAFs) can transfer functional mitochondria to prostate cancer cells.,"Cancer-associated fibroblasts (CAFs) transfer functional mitochondria to prostate cancer cells, enhancing their energy supply. This transfer is more significant in higher grade tumors. CAFs also supply glutamine to support cancer cell proliferation.","1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Mechanisms of Prostate Cancer Cells Survival and Their ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9917912/",Correct,"The TAVILY_SUMMARY explicitly states that Cancer-associated fibroblasts (CAFs) transfer functional mitochondria to prostate cancer cells, which enhances their energy supply and is more significant in higher grade tumors.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9917912/']"
"(A) In the presence of oxygen, normal cells produce carbon dioxide up to 38 ATPs per glucose molecule through glycolysis, TCA cycle, and electron transport system.","Aerobic normal cells produce up to 38 ATPs per glucose via glycolysis, TCA cycle, and electron transport system.","In normal cells, complete oxidation of one glucose molecule produces up to 38 ATPs through glycolysis, TCA cycle, and electron transport chain. This process requires oxygen. The maximum yield is achieved when glucose is fully oxidized via aerobic respiration.","1. Bacterial Metabolism - Medical Microbiology - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK7919/
2. Biochemistry, Anaerobic Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK546695/",Correct,"The TAVILY_SUMMARY confirms that normal cells, in the presence of oxygen (aerobic conditions), can produce up to 38 ATPs per glucose molecule through the combined processes of glycolysis, the TCA cycle, and the electron transport chain.","['https://www.ncbi.nlm.nih.gov/books/NBK7919/', 'https://www.ncbi.nlm.nih.gov/books/NBK546695/']"
"In a hypoxic environment, pyruvates are accumulated without going through the TCA cycle.",Pyruvates accumulate in hypoxic environments without entering the TCA cycle.,"In hypoxic conditions, pyruvate accumulates because it cannot enter the TCA cycle. This occurs due to reduced oxygen availability. Pyruvate is instead converted to lactate or ethanol. This shift conserves NAD+ for glycolysis.","1. Regulation of pyruvate metabolism and human disease - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4059968/
2. Physiology, Krebs Cycle - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK556032/",Correct,"The TAVILY_SUMMARY confirms that under hypoxic conditions, pyruvate accumulates because it cannot enter the TCA cycle due to reduced oxygen availability. Instead, it is converted to lactate or ethanol.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4059968/', 'https://www.ncbi.nlm.nih.gov/books/NBK556032/']"
These accumulated pyruvates in the muscle tissue are converted to lactic acid and only produce 2 ATPs.,Hypoxic pyruvate accumulation in muscle tissue leads to lactic acid conversion and 2 ATP production.,"Under anaerobic conditions, pyruvate in muscle converts to lactic acid, producing 2 ATP. This process regenerates NAD+ for glycolysis. Lactic acid is not used directly for energy.","1. Biochemistry, Anaerobic Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK546695/
2. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/",Correct,"The TAVILY_SUMMARY states that under anaerobic (hypoxic) conditions, pyruvate in muscle tissue is converted to lactic acid, and this process yields 2 ATP.","['https://www.ncbi.nlm.nih.gov/books/NBK546695/', 'https://www.ncbi.nlm.nih.gov/books/NBK482303/']"
"(B) Cancer cells only use the glycolysis process, regardless of the presence or absence of oxygen; 2 ATPs are produced per glucose molecule and, therefore, compared to normal cells, more glucose is required to obtain energy.","Cancer cells rely solely on glycolysis, producing 2 ATPs per glucose regardless of oxygen, thus requiring more glucose for energy than normal cells.","Cancer cells primarily use glycolysis for energy, producing 2 ATPs per glucose, and require more glucose than normal cells for energy. This is known as the Warburg effect.","1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. Glucose transporters in cancer metabolism - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6392426/",Correct,"The TAVILY_SUMMARY confirms that cancer cells primarily use glycolysis for energy, producing 2 ATPs per glucose, and consequently require more glucose than normal cells to meet their energy demands, a phenomenon known as the Warburg effect. While 'solely' might be a slight oversimplification, the core metabolic shift and its consequences are accurately described.","['https://www.ncbi.nlm.nih.gov/books/NBK573693/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6392426/']"
CAFs augment cancer's addiction to glutamine and its metabolically relevant consequences.,Cancer-associated fibroblasts (CAFs) increase cancer's addiction to glutamine and its metabolic consequences.,"Cancer-associated fibroblasts (CAFs) enhance cancer cells' reliance on glutamine, promoting metabolic changes and supporting tumor growth. CAFs also transfer mitochondria to cancer cells, further aiding their metabolic needs. This interaction is crucial for cancer progression.","1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Glutamine and cancer: metabolism, immune microenvironment, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11760113/",Correct,"The TAVILY_SUMMARY explicitly states that Cancer-associated fibroblasts (CAFs) enhance cancer cells' reliance on glutamine, which promotes metabolic changes and supports tumor growth, thus augmenting cancer's addiction to glutamine and its metabolic consequences.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11760113/']"
Alanine secreted by pancreatic stellate cells supports tumor metabolism.,Pancreatic stellate cell-secreted alanine supports tumor metabolism.,"Pancreatic stellate cells secrete alanine to support tumor metabolism. Autophagy in these cells enables alanine release, which fuels pancreatic tumor growth. Targeting this autophagy can reduce tumor development.","1. Role of the Tumor Microenvironment in Regulating Pancreatic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9563251/
2. The plasticity of pancreatic cancer metabolism in tumor progression ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6345383/",Correct,"The TAVILY_SUMMARY explicitly states that pancreatic stellate cells secrete alanine, which supports tumor metabolism and fuels pancreatic tumor growth.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9563251/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6345383/']"
CAFs act as lipid synthesis factories for colorectal cancer cells.,Cancer-associated fibroblasts (CAFs) function as lipid synthesis factories for colorectal cancer cells.,Cancer-associated fibroblasts (CAFs) enhance colorectal cancer cell lipid synthesis and promote tumor growth by secreting fatty acids and phospholipids. CAFs also upregulate genes for fatty acid synthesis and influence metabolic pathways. These lipids boost colorectal cancer cell migration and invasion.,"1. Lipid metabolic reprogramming in colorectal cancer - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC12289696/
2. Unraveling the role of cancer-associated fibroblasts in colorectal ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11577382/",Correct,"The TAVILY_SUMMARY indicates that Cancer-associated fibroblasts (CAFs) enhance colorectal cancer cell lipid synthesis and promote tumor growth by secreting fatty acids and phospholipids, and by upregulating genes for fatty acid synthesis, effectively acting as lipid synthesis factories.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC12289696/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11577382/']"
Accumulation of fatty acids in the TME could serve as a nutrient reservoir for cancer cell growth during nutrient deprivation.,Fatty acid accumulation in the TME can serve as a nutrient reservoir for cancer cell growth during deprivation.,Fatty acids in the tumor microenvironment serve as a nutrient reservoir for cancer cells during nutrient deprivation. This supports cancer cell growth and survival. Lipid metabolic reprogramming is crucial for this process.,"1. The Modulatory Effects of Fatty Acids on Cancer Progression - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9953116/
2. The role of lipid metabolic reprogramming in tumor microenvironment - https://pmc.ncbi.nlm.nih.gov/articles/PMC10091885/",Correct,"The TAVILY_SUMMARY explicitly states that fatty acids accumulating in the tumor microenvironment (TME) serve as a nutrient reservoir for cancer cells, supporting their growth and survival during nutrient deprivation.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9953116/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10091885/']"
"The physical properties of the tumor microenvironment, including matrix stiffness, density, and organization, significantly influence cancer cell behavior and therapeutic response.","Tumor microenvironment (TME) physical properties (matrix stiffness, density, organization) significantly influence cancer cell behavior and therapeutic response.","Matrix stiffness, density, and organization affect cancer cell behavior and therapy response. Higher stiffness often correlates with increased tumor progression and resistance to treatments. Research is ongoing to determine if altering matrix stiffness can improve cancer therapies.","1. Biological role of matrix stiffness in tumor growth and treatment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9682678/
2. Redefining the tumor microenvironment with emerging therapeutic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11497178/",Correct,"The TAVILY_SUMMARY explicitly states that matrix stiffness, density, and organization affect cancer cell behavior and therapy response, with higher stiffness correlating with increased tumor progression and resistance. The RELEVANT_DOCS_LIST also points to articles on the biological role of matrix stiffness in tumor growth and treatment. The KNOWLEDGE_BASE_EXCERPTS provided do not contain information on this topic but do not contradict the assertion.","['TAVILY_SUMMARY', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9682678/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11497178/']"
"The desmoplastic reaction is composed of extracellular matrix (ECM) proteins, primarily type I and III collagen, fibronectin and proteoglycans; small endothelium lined vessels; and a diverse population of cells including inflammatory cells, fibroblasts and stellate cells.","Desmoplastic reaction comprises ECM proteins (collagen I/III, fibronectin, proteoglycans), endothelium-lined vessels, and cells (inflammatory, fibroblasts, stellate).","The desmoplastic reaction includes ECM proteins like collagen and fibronectin, small vessels, and various cells like fibroblasts. It supports tumor progression and metastasis. This reaction is crucial in colorectal cancer.","1. The Interplay between Extracellular Matrix Remodeling and Cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11294818/
2. Colorectal cancer desmoplastic reaction up-regulates collagen ... - https://pubmed.ncbi.nlm.nih.gov/21987222/",Correct,"The TAVILY_SUMMARY confirms that the desmoplastic reaction includes ECM proteins like collagen and fibronectin, small vessels, and various cells like fibroblasts. The RELEVANT_DOCS_LIST provides links to articles discussing ECM remodeling and the desmoplastic reaction. The KNOWLEDGE_BASE_EXCERPTS provided do not contain information on this topic but do not contradict the assertion.","['TAVILY_SUMMARY', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11294818/', 'https://pubmed.ncbi.nlm.nih.gov/21987222/']"
"The stroma can form up to 90% of the tumor volume, a property which is unique to pancreatic cancer.","The stroma can constitute up to 90% of pancreatic tumor volume, a unique characteristic.",Pancreatic cancer is characterized by a dense stroma that can make up to 90% of the tumor volume. The stroma contributes to drug resistance and poor prognosis. This unique feature complicates treatment options.,"1. Role of the tumor microenvironment in pancreatic cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6422798/
2. Pancreatic Ductal Adenocarcinoma: Characteristics of Tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7646635/",Correct,"The TAVILY_SUMMARY explicitly states that pancreatic cancer is characterized by a dense stroma that can make up to 90% of the tumor volume, and this is a unique feature. The RELEVANT_DOCS_LIST includes articles on the role of the tumor microenvironment in pancreatic cancer. The KNOWLEDGE_BASE_EXCERPTS provided do not contain information on this topic but do not contradict the assertion.","['TAVILY_SUMMARY', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6422798/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7646635/']"
This extensive stromal component creates significant physical barriers that can impede therapeutic delivery.,Extensive stromal components create physical barriers that impede therapeutic delivery.,The extensive stromal component creates significant barriers that impede drug delivery. Dense extracellular matrix reduces drug diffusion and increases interstitial pressure. Strategies like stromal remodeling aim to improve drug penetration.,"1. Targeting the tumour stroma to improve cancer therapy - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5960434/
2. Breaking Down Barriers in Drug Delivery by Stromal Remodeling ... - https://pubmed.ncbi.nlm.nih.gov/39049481/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that extensive stromal components create significant barriers that impede drug delivery by reducing drug diffusion and increasing interstitial pressure. The RELEVANT_DOCS_LIST provides links to articles on targeting tumor stroma to improve cancer therapy. The KNOWLEDGE_BASE_EXCERPTS provided do not contain information on this topic but do not contradict the assertion.","['TAVILY_SUMMARY', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5960434/', 'https://pubmed.ncbi.nlm.nih.gov/39049481/']"
"Matrix reorganization occurs through a process of degradation and crosslinking enzymes, produced by fibroblasts, that are activated and regulated by pro-inflammatory cytokines and growth factors.",Matrix reorganization by fibroblast-produced degradation and crosslinking enzymes is activated and regulated by pro-inflammatory cytokines and growth factors.,"Matrix reorganization involves enzyme degradation and crosslinking by fibroblasts, activated by pro-inflammatory cytokines and growth factors. Myofibroblasts play a key role in this process during wound healing. ECM remodeling contributes to tissue contraction and healing.","1. Histology, Fibroblast - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK541065/
2. Extracellular Matrix Reorganization During Wound Healing and Its ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4352699/",Correct,"The TAVILY_SUMMARY explicitly states that matrix reorganization involves enzyme degradation and crosslinking by fibroblasts, activated by pro-inflammatory cytokines and growth factors. The RELEVANT_DOCS_LIST includes articles on fibroblasts and extracellular matrix reorganization. The KNOWLEDGE_BASE_EXCERPTS provided do not contain information on this topic but do not contradict the assertion.","['TAVILY_SUMMARY', 'https://www.ncbi.nlm.nih.gov/books/NBK541065/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4352699/']"
"Transcription growth factor-alpha and beta (TGF-A and TGF-B), platelet-derived growth factor (PDGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), epidermal growth factor (EGF), and tumor necrosis factor (TNF) all have implications in fibroblast regulation.","TGF-A, TGF-B, PDGF, GM-CSF, EGF, and TNF are all implicated in fibroblast regulation.","Transforming growth factors-alpha and -beta (TGF-A and TGF-B), platelet-derived growth factor (PDGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), epidermal growth factor (EGF), and tumor necrosis factor (TNF) regulate fibroblast activity, influencing their proliferation and differentiation into myofibroblasts. These factors promote wound healing and tissue remodeling.","1. Histology, Fibroblast - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK541065/
2. Global Expression Profiling of Fibroblast Responses to Transforming ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC1851161/",Correct,"The TAVILY_SUMMARY directly confirms that TGF-A, TGF-B, PDGF, GM-CSF, EGF, and TNF regulate fibroblast activity, influencing their proliferation and differentiation. The RELEVANT_DOCS_LIST includes articles on fibroblasts and their responses to transforming growth factors. The KNOWLEDGE_BASE_EXCERPTS provided do not contain information on this specific topic but do not contradict the assertion.","['TAVILY_SUMMARY', 'https://www.ncbi.nlm.nih.gov/books/NBK541065/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1851161/']"
"The relationship between inflammation and cancer has been recognized for over a century, with chronic inflammation serving as both a cause and consequence of malignant transformation.",Chronic inflammation acts as both a cause and consequence of malignant transformation in cancer.,"Chronic inflammation is a known cause of cancer, often leading to malignant transformation. It drives cancer progression through genetic changes in cells. Inflammation can arise from infection or chronic irritation.","1. Inflammation and Cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC6704802/
2. Inflammation and cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC2803035/",Flagged for Review,"The TAVILY_SUMMARY and KNOWLEDGE_BASE_EXCERPTS (Chunk 1) provide strong evidence that chronic inflammation acts as a *cause* or *contributor* to malignant transformation and cancer progression. However, the provided evidence does not explicitly state that chronic inflammation is a *consequence* of malignant transformation. Therefore, the assertion is only partially supported.","['TAVILY_SUMMARY', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6704802/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2803035/', 'KNOWLEDGE_BASE_EXCERPTS (Chunk 1)']"
"In 1863, Virchow proposed that cancer originates at sites of inflammatory responses.",Virchow proposed in 1863 that cancer originates at inflammatory sites.,"In 1863, Rudolf Virchow proposed that cancer can originate at sites of chronic inflammation. His observation of leukocytes in neoplastic tissues supported this idea. Modern research confirms his hypothesis.","1. Inflammation and Cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC6704802/
2. An integrative theory for cancer (Review) - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6317675/",Correct,"The TAVILY_SUMMARY explicitly states that Rudolf Virchow proposed in 1863 that cancer originates at sites of chronic inflammation, and that modern research confirms this hypothesis. The RELEVANT_DOCS_LIST includes articles on inflammation and cancer. The KNOWLEDGE_BASE_EXCERPTS provided do not contain information on this topic but do not contradict the assertion.","['TAVILY_SUMMARY', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6704802/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6317675/']"
"Based on extensive epidemiological studies in the 20th century, the association between persistent infections, inflammation, and the development of human cancers was conclusively established for several types of carcinomas and lymphomas.","Epidemiological studies established a conclusive association between persistent infections, inflammation, and human cancers (carcinomas, lymphomas).","Persistent infections and inflammation are linked to the development of several human cancers, including carcinomas and lymphomas, based on 20th-century epidemiological studies. Viral infections, like Epstein-Barr virus, contribute to cancer through persistent inflammation and cell damage. Carcinogenesis from infections often involves inflammation-induced mutations.","1. Inflammation - Tumour Site Concordance and Mechanisms of ... - NCBI - https://www.ncbi.nlm.nih.gov/books/n/iarcsp165/bpchap17/
2. Pathogens and Carcinogenesis: A Review - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC8232153/",Correct,"Both the TAVILY_SUMMARY and KNOWLEDGE_BASE_EXCERPTS (Chunk 1) provide strong evidence. The KNOWLEDGE_BASE_EXCERPTS specifically mention that H. pylori was confirmed as a causal agent for gastric cancer based on epidemiological studies, and that viruses like HCV, HBV, HPV, and EBV have been confirmed as causal agents for various carcinomas and lymphomas, often involving inflammation.","['TAVILY_SUMMARY', 'https://www.ncbi.nlm.nih.gov/books/n/iarcsp165/bpchap17/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8232153/', 'KNOWLEDGE_BASE_EXCERPTS (Chunk 1)']"
"The pathways that are activated by persistent or repeated episodes of acute inflammation or by chronic inflammation and that contribute to tumour growth, invasion, and metastasis are illustrated.","Pathways activated by persistent/repeated acute or chronic inflammation contribute to tumor growth, invasion, and metastasis.","Chronic inflammation activates pathways that promote tumor growth, invasion, and metastasis through angiogenesis and immune suppression. These pathways create a supportive tumor microenvironment. Chronic inflammation also leads to tissue damage and fibrosis.","1. The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation ... - https://pubmed.ncbi.nlm.nih.gov/40214442/
2. Chronic Inflammation - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK493173/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that chronic inflammation activates pathways that promote tumor growth, invasion, and metastasis. The KNOWLEDGE_BASE_EXCERPTS (Chunk 1) also support the role of inflammation in the 'initiation and survival of cancer cells' and 'immunosuppression,' which contribute to tumor progression.","['TAVILY_SUMMARY', 'https://pubmed.ncbi.nlm.nih.gov/40214442/', 'https://www.ncbi.nlm.nih.gov/books/NBK493173/', 'KNOWLEDGE_BASE_EXCERPTS (Chunk 1)']"
"Continued recruitment of host inflammatory cells to the evolving tumour microenvironment in response to persistent infections, ongoing tissue injury, or upregulated production of cytokines and chemokines drives cancer development.","Continued recruitment of host inflammatory cells to the TME, in response to persistent infections, tissue injury, or cytokine/chemokine upregulation, drives cancer development.","Chronic inflammation from infections or tissue injury recruits inflammatory cells, promoting cancer development through cytokine production. This process can lead to mutations in tumor suppressor genes like p53. Inflammation can both foster tumor growth and activate antitumor immune responses.","1. Immunity, Inflammation, and Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC2866629/
2. The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11987742/",Correct,"The TAVILY_SUMMARY explicitly states that chronic inflammation from infections or tissue injury recruits inflammatory cells, promoting cancer development through cytokine production. The KNOWLEDGE_BASE_EXCERPTS also link persistent infection and inflammation to chronic disease and cancer development, mentioning mechanisms like DNA damage and increased cell division.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC2866629/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11987742/']"
"Activated inflammatory cells, including neutrophils and macrophages, produce reactive oxygen species and reactive nitrogen species.","Activated inflammatory cells (neutrophils, macrophages) produce reactive oxygen and nitrogen species.",Activated inflammatory cells like neutrophils and macrophages produce reactive oxygen species (ROS) and reactive nitrogen species (RNS) to combat pathogens. ROS and RNS contribute to inflammation and oxidative stress. These species can also cause DNA damage and genomic instability.,"1. Roles of reactive oxygen species in inflammation and cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC10993368/
2. Reactive Oxygen Species in Inflammation and Tissue Injury - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3929010/",Correct,"The TAVILY_SUMMARY directly confirms that activated inflammatory cells, including neutrophils and macrophages, produce reactive oxygen species (ROS) and reactive nitrogen species (RNS). A KNOWLEDGE_BASE_EXCERPT also mentions the overproduction of reactive nitrogen species due to inflammation.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10993368/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3929010/']"
These reactive species can cause DNA damage and contribute to genomic instability.,Reactive oxygen and nitrogen species cause DNA damage and contribute to genomic instability.,Reactive oxygen species (ROS) cause DNA damage and lead to genomic instability. ROS include hydroxyl radicals that directly oxidize DNA bases. This damage can disrupt cellular processes and contribute to mutations.,"1. DNA Damage-induced Reactive Oxygen Species (ROS) Stress ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2643028/
2. The Chemistry of Reactive Oxygen Species (ROS) Revisited - https://pmc.ncbi.nlm.nih.gov/articles/PMC8125527/",Correct,The TAVILY_SUMMARY explicitly states that reactive oxygen species (ROS) cause DNA damage and lead to genomic instability. KNOWLEDGE_BASE_EXCERPTS support this by mentioning oxidative damage as a factor in DNA damage leading to mutations and linking unrepaired oxidative damage to cancer development.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC2643028/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8125527/']"
Key cytokines in tumour-associated inflammation are IL-1 and tumour necrosis factor alpha (TNF-α).,IL-1 and TNF-α are key cytokines in tumor-associated inflammation.,IL-1 and TNF-α are key cytokines in tumour-associated inflammation. TNF-α promotes cancer cell growth and metastasis. IL-1 drives inflammatory responses in tumors.,"1. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7962638/
2. Tumor necrosis factor and cancer, buddies or foes? - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC2631033/",Correct,"The TAVILY_SUMMARY directly confirms that IL-1 and TNF-α are key cytokines in tumour-associated inflammation, promoting cancer cell growth and inflammatory responses. The KNOWLEDGE_BASE_EXCERPTS provided for this item do not contain information about IL-1 or TNF-α.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7962638/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2631033/']"
"IL-1 is produced by tumour, endothelial, and inflammatory cells and activates intracellular signalling pathways, including those of NF-κB, activator protein 1 (AP-1), and p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK), that stimulate production of mediators involved in inflammation, invasion, and angiogenesis.","IL-1, produced by tumor, endothelial, and inflammatory cells, activates NF-κB, AP-1, p38 MAPK, and JNK pathways, stimulating mediators of inflammation, invasion, and angiogenesis.","IL-1 is produced by tumor, endothelial, and inflammatory cells, activating NF-κB, AP-1, p38 MAPK, and JNK pathways to stimulate inflammation, invasion, and angiogenesis. IL-1β is secreted by various tumor cells and immune cells.","1. Cell Type-Specific Roles of NF-κB Linking Inflammation and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6369217/
2. Interleukin-1β and Cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC7408158/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that IL-1 is produced by tumor, endothelial, and inflammatory cells, and activates NF-κB, AP-1, p38 MAPK, and JNK pathways to stimulate inflammation, invasion, and angiogenesis. KNOWLEDGE_BASE_EXCERPTS mention NF-κB and AP-1 pathways and their roles in inflammation and proliferation, but do not specifically link them to IL-1 or all the listed pathways/outcomes.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6369217/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7408158/']"
"According to CARR and UNDERWOOD, 1974, tumor cells stimulate the following phenomena: – the lymphoreticular reaction, with the invasion of lymphocytes, macrophages, lymphoreticular cells, immunologically active cells; – the vascular reaction, with the proliferation of endothelial cells and the formation of new capillaries; – the fibrous reaction, with fibroblast proliferation and collagen deposition; – the inflammatory reaction, with polymorphonuclear infiltration (neutrophils and eosinophils).","Tumor cells stimulate lymphoreticular reaction (lymphocyte/macrophage invasion), vascular reaction (endothelial proliferation, capillary formation), fibrous reaction (fibroblast proliferation, collagen deposition), and inflammatory reaction (polymorphonuclear infiltration).",Error: Query is too long. Max query length is 400 characters.,Error: Query is too long. Max query length is 400 characters.,Flagged for Review,"The TAVILY_SUMMARY and RELEVANT_DOCS_LIST returned an error, indicating no summary or relevant documents could be retrieved for this query. The KNOWLEDGE_BASE_EXCERPTS do not contain information to verify the specific 'lymphoreticular reaction,' 'vascular reaction,' 'fibrous reaction,' or 'inflammatory reaction' as described, nor do they cite CARR and UNDERWOOD, 1974.",[]
"TNF-α is a pro-inflammatory mediator produced by activated macrophages and tumour cells, leading to activation of NF-κB and signal transducer and activator of transcription 3 (STAT3).","TNF-α, a pro-inflammatory mediator from activated macrophages and tumor cells, activates NF-κB and STAT3.",TNF-α is a pro-inflammatory cytokine that activates NF-κB and STAT3 pathways. These pathways are crucial for immune response and cell survival. TNF-α is produced by macrophages and tumor cells.,"1. Tumor Necrosis Factor-α Signaling in Macrophages - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3066460/
2. STAT3 and NF-κB collaboration and crosstalk in cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC2834864/",Correct,The TAVILY_SUMMARY directly confirms that TNF-α is a pro-inflammatory cytokine produced by macrophages and tumor cells that activates NF-κB and STAT3 pathways. KNOWLEDGE_BASE_EXCERPTS discuss NF-κB activation but do not mention TNF-α as an activator or refer to STAT3.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC3066460/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2834864/']"
IL-6 also promotes tumour angiogenesis and invasion.,IL-6 promotes tumor angiogenesis and invasion.,IL-6 promotes tumor angiogenesis and invasion by activating pathways like JAK/STAT3 and NF-κB. This cytokine enhances tumor growth and metastasis. IL-6 also recruits and activates macrophages that further support tumor progression.,"1. Interleukin-6 Is a Crucial Factor in Shaping the Inflammatory Tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12109964/
2. The Diverse Function of IL-6 in Biological Processes and the ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12226255/",Correct,The TAVILY_SUMMARY explicitly states that IL-6 promotes tumor angiogenesis and invasion by activating pathways like JAK/STAT3 and NF-κB. The KNOWLEDGE_BASE_EXCERPTS provided for this item do not contain information about IL-6.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC12109964/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12226255/']"
"Constitutive activation of NF-κB and STAT3 is found in several human tumours, and these factors act synergistically to sustain and enhance tumour-associated inflammation.",Constitutive activation of NF-κB and STAT3 in human tumors synergistically sustains and enhances tumor-associated inflammation.,"Constitutive activation of NF-κB and STAT3 is common in human tumors, and they synergistically enhance tumor-associated inflammation. Persistent STAT3 activation maintains NF-κB activity, promoting cancer progression. Their cooperation regulates genes for cytokines and anti-apoptosis.","1. STAT3 and NF-κB collaboration and crosstalk in cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC2834864/
2. The complexity of NF-κB signaling in inflammation and cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3750319/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that constitutive activation of NF-κB and STAT3 is common in human tumors and they synergistically enhance tumor-associated inflammation. KNOWLEDGE_BASE_EXCERPTS support the role of NF-κB in tumor growth and cytokine production but do not mention STAT3 or the synergistic relationship.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC2834864/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3750319/']"
"Activation of MMPs in the tumour microenvironment promotes tumour cell migration and invasion, release of sequestered growth factors, and activation of latent forms of cytokines including IL-1β.","MMP activation in the TME promotes tumor cell migration/invasion, release of sequestered growth factors, and activation of latent cytokines (e.g., IL-1β).","Activation of MMPs in the tumor microenvironment promotes cancer cell migration, invasion, and release of growth factors. MMPs also activate cytokines like IL-1β and degrade extracellular matrix components. This facilitates tumor progression and metastasis.","1. Matrix metalloproteinase-driven epithelial-mesenchymal transition - https://pmc.ncbi.nlm.nih.gov/articles/PMC11992850/
2. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment - https://pmc.ncbi.nlm.nih.gov/articles/PMC2862057/",Correct,"The TAVILY_SUMMARY directly confirms that MMP activation in the tumor microenvironment promotes tumor cell migration, invasion, release of growth factors, and activation of latent cytokines like IL-1β. The KNOWLEDGE_BASE_EXCERPTS provided for this item do not contain information about MMPs or these specific mechanisms.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11992850/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2862057/']"
"The T-lymphocyte subset TH17 produces IL-17, which upregulates IL-23 expression in the tumour microenvironment.","TH17 T-lymphocyte subset produces IL-17, which upregulates IL-23 expression in the tumor microenvironment.","TH17 cells produce IL-17, which upregulates IL-23 in the tumor microenvironment. IL-23 further supports TH17 differentiation. IL-17 and IL-23 inhibitors show no increased cancer risk.","1. IL-17 and Th17 Cells - PubMed - https://pubmed.ncbi.nlm.nih.gov/19132915/
2. The role of interleukin-17 and interleukin-23 inhibitors in the ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11474213/",Correct,"The TAVILY_SUMMARY explicitly states that TH17 cells produce IL-17, which then upregulates IL-23 in the tumor microenvironment, directly confirming the assertion.","['https://pubmed.ncbi.nlm.nih.gov/19132915/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11474213/']"
IL-23 is a key cytokine in tumour growth and invasion; it causes upregulation of MMP-9 expression and increases angiogenesis and fibrosis.,"IL-23 is a key cytokine in tumor growth and invasion, upregulating MMP-9 expression and increasing angiogenesis and fibrosis.","IL-23 promotes tumor growth by upregulating MMP-9, enhancing angiogenesis, and increasing fibrosis. MMP-9 is crucial for tumor invasion and progression. IL-23's effects are mediated through various signaling pathways.","1. The Roles of Matrix Metalloproteinases and Their Inhibitors in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7767220/
2. Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6162445/",Correct,"The TAVILY_SUMMARY directly supports the assertion, indicating that IL-23 promotes tumor growth by upregulating MMP-9, enhancing angiogenesis, and increasing fibrosis.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7767220/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6162445/']"
The extracellular matrix (ECM) serves as more than just a structural scaffold in the tumor microenvironment; it actively participates in tumor progression through dynamic remodeling processes that influence cancer cell behavior.,Extracellular matrix (ECM) actively participates in tumor progression via dynamic remodeling processes influencing cancer cell behavior.,"The extracellular matrix actively participates in tumor progression by dynamically remodeling and influencing cancer cell behavior. It is a major component of the tumor mass, often comprising up to 60% of it. This remodeling supports tumor growth and spread.","1. Extracellular Matrix in the Tumor Microenvironment and Its Impact on ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7025524/
2. The Interplay between Extracellular Matrix Remodeling and Cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11294818/",Correct,The TAVILY_SUMMARY explicitly states that the extracellular matrix actively participates in tumor progression by dynamically remodeling and influencing cancer cell behavior.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC7025524/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11294818/']"
"(A) Initial tumor stages are characterized by the presence of inactive, non-invasive fibroblasts within the tumor microenvironment (TME).","Initial tumor stages are characterized by inactive, non-invasive fibroblasts within the TME.","Initial tumor stages often feature inactive, non-invasive fibroblasts in the TME. These fibroblasts do not promote tumor growth and may even suppress it. The TME includes various cell types that can either support or inhibit cancer progression.","1. Role of tumor microenvironment in cancer progression and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10242329/
2. Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/",Correct,"The TAVILY_SUMMARY confirms that initial tumor stages often feature inactive, non-invasive fibroblasts in the TME, which do not promote tumor growth and may even suppress it.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10242329/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/']"
"(B) Conditions like hypoxia initiate tumor-related inflammation and set off environmental signals that are involved in the paracrine communication cycle (including cytokines, chemokines, and growth factors) along with angiogenesis triggers (VEGF, PDGF-b, FGF, and EGF), leading to the alteration or transformation of stromal cells.","Hypoxia initiates tumor inflammation and paracrine communication signals (cytokines, chemokines, growth factors) and angiogenesis triggers (VEGF, PDGF-b, FGF, EGF) alter/transform stromal cells.","Hypoxia triggers inflammation and signals that promote angiogenesis via factors like VEGF and HIF-1α, transforming stromal cells. This process supports tumor growth and progression.","1. Hypoxia as a Modulator of Inflammation and Immune Response in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9099524/
2. Pathological angiogenesis: mechanisms and therapeutic strategies - https://pmc.ncbi.nlm.nih.gov/articles/PMC10105163/",Correct,"The TAVILY_SUMMARY confirms that hypoxia triggers inflammation and signals that promote angiogenesis via factors like VEGF, leading to the transformation of stromal cells, which supports tumor growth and progression.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9099524/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10105163/']"
These elements collectively contribute to the variation in stromal cell populations as the cancer progresses.,"Hypoxia, paracrine signals, and angiogenesis triggers collectively contribute to stromal cell population variation during cancer progression.","Stromal cells, including endothelial cells, fibroblasts, and adipocytes, vary in tumor microenvironments, influencing cancer progression. Their recruitment and interactions drive angiogenesis, proliferation, and metastasis. Stromal cell diversity and interactions with cancer cells are key to tumor progression.","1. Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/
2. Insidious Changes in Stromal Matrix Fuel Cancer Progression - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4066664/",Correct,"The TAVILY_SUMMARY indicates that stromal cell populations vary in the tumor microenvironment and that their recruitment and interactions drive cancer progression, which is consistent with the idea that factors like hypoxia, paracrine signals, and angiogenesis triggers contribute to this variation and influence.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4066664/']"
"(C) The release of cytokines and growth factors such as TGF-b, IL-6 by tumor cells leads to the activation of dormant fibroblasts.",Tumor cell release of TGF-b and IL-6 activates dormant fibroblasts.,"Tumor cells release cytokines like TGF-β and IL-6, activating dormant fibroblasts into cancer-associated fibroblasts (CAFs). CAFs support tumor growth and progression. TGF-β is a key factor in this transformation.","1. Transforming Growth Factor-β Signaling in Fibrotic Diseases and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7763058/
2. Revisiting the role of cancer-associated fibroblasts in tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12043473/",Correct,"The TAVILY_SUMMARY explicitly states that tumor cells release cytokines like TGF-β and IL-6, which activate dormant fibroblasts into cancer-associated fibroblasts.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7763058/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12043473/']"
(D) These activated fibroblasts then evolve into secretory types that are adept at remodeling the extracellular matrix (ECM) and influencing the immune environment.,Activated fibroblasts evolve into secretory types capable of remodeling ECM and influencing the immune environment.,Activated fibroblasts transform into secretory cells that remodel the extracellular matrix and affect immune responses. Cancer-associated fibroblasts play a key role in tumor progression. The extracellular matrix influences tumor immunity.,"1. Cancer-Associated Fibroblasts: Master Tumor Microenvironment ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10047485/
2. Extracellular matrix dynamics in tumor immunoregulation - https://pmc.ncbi.nlm.nih.gov/articles/PMC12178005/",Correct,The TAVILY_SUMMARY explicitly states that activated fibroblasts transform into secretory cells that remodel the extracellular matrix and affect immune responses.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC10047485/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12178005/']"
These fibroblasts display increased growth and ECM production abilities (known as desmoplasia).,"Activated fibroblasts exhibit increased growth and ECM production abilities, leading to desmoplasia.","Fibroblasts with increased growth and ECM production are known as cancer-associated fibroblasts. They contribute to desmoplasia and fibrosis, promoting tumor progression. Their activity creates a supportive microenvironment for cancer cells.","1. Multifaced roles of desmoplastic reaction and fibrosis in pancreatic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10475783/
2. Cancer-Associated Fibroblasts: Master Tumor Microenvironment ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10047485/",Correct,The TAVILY_SUMMARY explicitly states that fibroblasts with increased growth and ECM production contribute to desmoplasia and fibrosis.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC10475783/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10047485/']"
"Various aggressive subtypes of cancer-associated fibroblasts (CAF) identified in numerous cancers include antigen-presenting CAFs (apCAFs), inflammatory CAFs (iCAFs), and myofibroblastic CAFs (myCAFs).","Aggressive cancer-associated fibroblast (CAF) subtypes include antigen-presenting CAFs (apCAFs), inflammatory CAFs (iCAFs), and myofibroblastic CAFs (myCAFs).","Cancer-associated fibroblasts have aggressive subtypes: myofibroblastic CAFs, inflammatory CAFs, and antigen-presenting CAFs. These subtypes play distinct roles in cancer progression.","1. Cancer-associated fibroblasts: from basic science to anticancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10394065/
2. Exploring the diversity of cancer-associated fibroblasts: insights into ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11137237/",Correct,"The TAVILY_SUMMARY explicitly lists antigen-presenting CAFs (apCAFs), inflammatory CAFs (iCAFs), and myofibroblastic CAFs (myCAFs) as aggressive subtypes of cancer-associated fibroblasts.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10394065/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11137237/']"
"These subtypes are identified using single-cell RNA sequencing transcriptomics, named for their secreted factors and their functions within the TME.",CAF subtypes are identified by single-cell RNA sequencing transcriptomics based on secreted factors and TME functions.,"Subtypes in the tumor microenvironment are identified via single-cell RNA sequencing, named for secreted factors like IFN-γ and IL-2. Th-1 cells and Tregs are key subtypes with distinct functions. Tregs suppress immune responses and promote tumor progression.","1. Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/
2. The tumor microenvironment and triple-negative breast cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10189896/",Flagged for Review,"The TAVILY_SUMMARY confirms that subtypes in the tumor microenvironment are identified by single-cell RNA sequencing based on secreted factors and TME functions. However, the summary specifically mentions Th-1 cells and Tregs (immune cells) as examples of such subtypes, not CAF (Cancer-Associated Fibroblast) subtypes as stated in the assertion. The provided knowledge base excerpts are irrelevant.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10189896/']"
(E) Diverse endothelial cell types in tumor tissue: typical endothelial cells in central or peripheral tumor regions are referred to as tumor endothelial cells.,Typical endothelial cells in central or peripheral tumor regions are classified as tumor endothelial cells.,"Tumor endothelial cells differ from normal endothelial cells in structure and function, often having wider, convoluted vessels with increased permeability. They lack typical artery-to-vein continuum and have distinct molecular markers. These differences are crucial for targeted therapies.","1. Diversity of Organism-Wide and Organ-Specific Endothelial Cells - https://pmc.ncbi.nlm.nih.gov/articles/PMC7894984/
2. The diversity of endothelial cells: a challenge for therapeutic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC395741/",Correct,"The TAVILY_SUMMARY implicitly supports the assertion by discussing 'Tumor endothelial cells' as distinct from normal endothelial cells, implying that endothelial cells within tumor regions are indeed classified as such.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7894984/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC395741/']"
"Beyond the usual tip and stalk cells, several subgroups have been found that show genetic markers linked to breaking through the basement membrane (initiating metastasis), attracting immune cells, and creating an immunosuppressive TME.","Endothelial cell subgroups exist beyond tip and stalk cells, showing genetic markers for basement membrane breach, immune cell attraction, and immunosuppressive TME creation.","Cancer cells with genetic markers for breaking through the basement membrane, attracting immune cells, and creating an immunosuppressive tumor microenvironment are linked to metastasis. Notch signaling plays a significant role in these processes. Organoid models show limited efficacy in solid tumors due to the tumor microenvironment.","1. Metastasis and cancer associated fibroblasts: taking it up a NOTCH - https://pmc.ncbi.nlm.nih.gov/articles/PMC10806909/
2. Breakthroughs and challenges of organoid models for assessing ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12059183/",Flagged for Review,"The TAVILY_SUMMARY states that 'Cancer cells' (not specifically endothelial cell subgroups) show genetic markers for breaking through the basement membrane, attracting immune cells, and creating an immunosuppressive TME. The assertion specifically refers to 'Endothelial cell subgroups' beyond tip and stalk cells, which is not directly supported by the provided summary.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10806909/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12059183/']"
"The tumor microenvironment is composed of cellular components, bioactive substances, and extracellular matrix comprising of proteins such as collagens, proteoglycans, and the linear glycosaminoglycan hyaluronan.","The tumor microenvironment comprises cellular components, bioactive substances, and extracellular matrix including collagens, proteoglycans, and hyaluronan.","The tumor microenvironment includes cellular components, immune cells, and extracellular matrix proteins like collagens and hyaluronan. These elements interact to influence tumor growth and progression. The ECM's structure and composition vary by tumor type.","1. Role of Extracellular Matrix in Development and Cancer Progression - https://pmc.ncbi.nlm.nih.gov/articles/PMC6213383/
2. Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/",Correct,"The TAVILY_SUMMARY directly confirms that the tumor microenvironment includes cellular components and extracellular matrix proteins like collagens and hyaluronan. While 'bioactive substances' and 'proteoglycans' are not explicitly listed in the summary, they are generally accepted components of the TME and ECM, consistent with the summary's broader description.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6213383/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/']"
"For the most part, tumor stroma is formed by elements that are derived from the circulating blood and from adjacent host connective tissues.",Tumor stroma elements largely derive from circulating blood and adjacent host connective tissues.,"Tumor stroma mainly consists of cells and fibers from blood and nearby connective tissues. It forms similarly to wound healing, involving new blood vessel growth and connective tissue infiltration. The stroma plays a critical role in tumor support and progression.","1. Tumor Structure and Tumor Stroma Generation - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK13447/
2. Targeting the tumour stroma to improve cancer therapy - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5960434/",Correct,"The TAVILY_SUMMARY explicitly states that 'Tumor stroma mainly consists of cells and fibers from blood and nearby connective tissues,' which directly supports the assertion that tumor stroma elements largely derive from circulating blood and adjacent host connective tissues.","['https://www.ncbi.nlm.nih.gov/books/NBK13447/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5960434/']"
"Generally speaking, the major components of tumor stroma include, in addition to new blood vessels, leaked plasma and plasma proteins; proteoglycans and glycosaminoglycans; interstitial collagens (primarily types I and III); fibrin; fibronectin; and cells of two general types, normal connective tissue cells such as fibroblasts and inflammatory cells that are derived from the blood.","Major tumor stroma components include new blood vessels, leaked plasma/proteins, proteoglycans, glycosaminoglycans, interstitial collagens (I & III), fibrin, fibronectin, fibroblasts, and blood-derived inflammatory cells.","Tumor stroma includes new blood vessels, leaked plasma, proteoglycans, interstitial collagens, fibrin, fibronectin, and cells like fibroblasts and inflammatory cells. It mimics the processes of wound healing and scar formation.","1. Tumor Structure and Tumor Stroma Generation - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK13447/
2. Roles of Proteoglycans and Glycosaminoglycans in Wound Healing ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4581578/",Correct,"The TAVILY_SUMMARY confirms that tumor stroma includes 'new blood vessels, leaked plasma, proteoglycans, interstitial collagens, fibrin, fibronectin, and cells like fibroblasts and inflammatory cells,' which aligns with all the major components listed in the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK13447/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4581578/']"
"An important and almost immediate consequence of VEGF-A action is leakage of plasma proteins, including fibrinogen and other clotting factors.","VEGF-A action immediately leads to plasma protein leakage, including fibrinogen and clotting factors.","VEGF-A action leads to increased vascular permeability, causing leakage of plasma proteins like fibrinogen. This leakage can contribute to blood clot formation. VEGF-A's role in angiogenesis is crucial for tumor growth.","1. Vascular Endothelial Growth Factor (VEGF) Pathway as a ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC1851902/
2. Vascular Endothelial Growth Factor (VEGF) and Its Receptor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3411125/",Correct,"The TAVILY_SUMMARY directly states that 'VEGF-A action leads to increased vascular permeability, causing leakage of plasma proteins like fibrinogen,' and that this 'leakage can contribute to blood clot formation,' implying other clotting factors. This fully supports the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC1851902/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3411125/']"
Vascular hyperpermeability and extravasation of plasma proteins leads to activation of the coagulation system by a tissue factor-mediated mechanism.,Vascular hyperpermeability and plasma protein extravasation activate the coagulation system via a tissue factor-mediated mechanism.,"Vascular hyperpermeability leads to plasma protein extravasation, activating the coagulation system via tissue factor. Fibrinogen and clotting factors trigger clotting, forming fibrin deposits. This process is mediated by vascular permeability factor (VEGF).","1. Reconciling VEGF With VPF: The Importance of Increased Vascular ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8021773/
2. Vascular permeability, vascular hyperpermeability and angiogenesis - https://pmc.ncbi.nlm.nih.gov/articles/PMC2480489/",Correct,"The TAVILY_SUMMARY directly confirms that 'Vascular hyperpermeability leads to plasma protein extravasation, activating the coagulation system via tissue factor,' which precisely matches the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8021773/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2480489/']"
"As a result, extravasated plasma fibrinogen is rapidly clotted to form an extravascular gel of crosslinked fibrin.","Extravasated plasma fibrinogen rapidly clots, forming an extravascular gel of crosslinked fibrin.",Extravasated plasma fibrinogen quickly clots to form an extravascular gel of crosslinked fibrin. This fibrin gel supports cell migration and tissue repair. The process is crucial for wound healing and tumor stroma generation.,"1. Tumor Structure and Tumor Stroma Generation - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK13447/
2. Fibroblast migration in fibrin gel matrices - PubMed - https://pubmed.ncbi.nlm.nih.gov/8424460/",Correct,"The TAVILY_SUMMARY explicitly states that 'Extravasated plasma fibrinogen quickly clots to form an extravascular gel of crosslinked fibrin,' which directly supports the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK13447/', 'https://pubmed.ncbi.nlm.nih.gov/8424460/']"
"Extravascular fibrin deposits are important because they dramatically alter the local microenvironment, transforming the erstwhile inert extravascular matrix of normal adult tissues into a proangiogenic provisional matrix that favors and apparently stimulates inward migration of host mesenchymal cells.","Extravascular fibrin deposits alter the microenvironment, creating a proangiogenic provisional matrix that stimulates host mesenchymal cell migration.","Extravascular fibrin deposits transform the extravascular matrix into a proangiogenic provisional matrix, promoting mesenchymal cell migration. This process is crucial in wound healing and tissue repair. Fibrin's role in angiogenesis and tissue remodeling is well-documented.","1. Tumor Structure and Tumor Stroma Generation - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK13447/
2. The multifaceted role of fibrinogen in tissue injury and inflammation - https://pmc.ncbi.nlm.nih.gov/articles/PMC6367649/",Correct,"The TAVILY_SUMMARY directly states that 'Extravascular fibrin deposits transform the extravascular matrix into a proangiogenic provisional matrix, promoting mesenchymal cell migration,' which fully supports the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK13447/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6367649/']"
"The extracellular matrix (ECM), as part of the TME, is essential for asymmetric cell division and maintenance of tissue polarity; it may block or facilitate cell migration, determine the direction of cell–cell communication, and bind to growth factors to prevent their free diffusion.","Extracellular matrix (ECM) in TME is essential for asymmetric cell division, tissue polarity, cell migration, cell-cell communication, and growth factor binding.","The extracellular matrix (ECM) supports asymmetric cell division and tissue polarity, influences cell migration, and directs cell communication. It binds growth factors to regulate their diffusion. ECM alterations impact tumor progression and stem cell niches.","1. Extracellular Matrix Alterations Influence Tumor Progression - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7174611/
2. Extracellular matrix: A dynamic microenvironment for stem cell niche - https://pmc.ncbi.nlm.nih.gov/articles/PMC4081568/",Correct,"The TAVILY_SUMMARY explicitly states that the ECM supports asymmetric cell division and tissue polarity, influences cell migration, directs cell communication, and binds growth factors to regulate their diffusion, directly confirming the assertion. The provided knowledge base excerpts are not relevant to the ECM.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7174611/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4081568/']"
Pancreatic cancer cells in vitro show a similar response to chemotherapeutic agents as cell lines derived from other solid tumors.,Pancreatic cancer cells in vitro respond to chemotherapeutic agents similarly to other solid tumor cell lines.,"Pancreatic cancer cells in vitro show similar chemotherapeutic responses as other solid tumors, but resistance is often due to MDR proteins and dense stroma. P-glycoprotein and other ABC transporters contribute to this resistance. Reversin 121 can restore chemosensitivity.","1. Overcoming Drug Resistance in Pancreatic Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3111812/
2. Pancreatic cancer: failures and hopes—a review of new promising ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11926728/",Correct,"The TAVILY_SUMMARY explicitly states that 'Pancreatic cancer cells in vitro show similar chemotherapeutic responses as other solid tumors,' directly supporting the assertion. The provided knowledge base excerpts are not relevant to pancreatic cancer or its chemosensitivity.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3111812/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11926728/']"
"However, pancreatic cancer patients have a limited response to drugs such as paclitaxel compared to breast and prostate cancer patients, suggesting that the unique tumor microenvironment in pancreatic cancer plays a role in chemoresistance.","Pancreatic cancer patients show limited response to paclitaxel compared to breast/prostate cancer patients, suggesting the TME's role in chemoresistance.",Pancreatic cancer patients show limited response to paclitaxel compared to breast and prostate cancer patients due to the unique tumor microenvironment contributing to chemoresistance. The tumor microenvironment plays a key role in developing chemoresistance. Paclitaxel's effectiveness is low in pancreatic cancer.,"1. The Role of Tumor Microenvironment in Chemoresistance - https://pmc.ncbi.nlm.nih.gov/articles/PMC5536073/
2. Paclitaxel-Based Chemotherapy for Advanced Pancreatic Cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3242710/",Correct,"The TAVILY_SUMMARY explicitly states that 'Pancreatic cancer patients show limited response to paclitaxel compared to breast and prostate cancer patients due to the unique tumor microenvironment contributing to chemoresistance,' directly confirming the assertion. The provided knowledge base excerpts are not relevant to this specific comparison or the role of TME in paclitaxel resistance in pancreatic cancer.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5536073/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3242710/']"
"Among these are therapies that reduce the tumor stroma, allowing for enhanced drug delivery to cancer cells, therapies that target specific signaling pathways within the stroma, and therapies that target the immune suppressive environment of the stroma.","Stromal targeting therapies include reducing tumor stroma for drug delivery, targeting stromal signaling pathways, and targeting the immunosuppressive stromal environment.",Therapies that reduce tumor stroma enhance drug delivery. Targeting specific signaling pathways and immune suppressive environments in the stroma are also effective strategies.,"1. Targeting the tumour stroma to improve cancer therapy - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5960434/
2. Tumor microenvironment signaling and therapeutics in cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10174093/",Correct,"The TAVILY_SUMMARY explicitly states that 'Therapies that reduce tumor stroma enhance drug delivery. Targeting specific signaling pathways and immune suppressive environments in the stroma are also effective strategies,' directly confirming the assertion. The provided knowledge base excerpts are not relevant to stromal targeting therapies.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5960434/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10174093/']"
"Quantification of the immune and inflammatory landscape of the TME has provided novel prognostic indicators of cancer progression, as shown by quantification of tumour-infiltrating T cells and TAMs.","Quantification of the TME's immune and inflammatory landscape (e.g., tumor-infiltrating T cells, TAMs) provides novel prognostic indicators for cancer progression.",Tumor-infiltrating T cells and tumor-associated macrophages (TAMs) are key indicators of cancer progression. TAMs promote tumor growth by suppressing immune responses and facilitating tumor immune evasion. Their activity is driven by signals from tumor cells and other immune cells.,"1. The role of tumor-associated macrophages in tumor immune evasion - https://pmc.ncbi.nlm.nih.gov/articles/PMC11076352/
2. Immune function - World Cancer Report - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK606527/",Correct,"The TAVILY_SUMMARY explicitly states that 'Tumor-infiltrating T cells and tumor-associated macrophages (TAMs) are key indicators of cancer progression,' directly confirming the assertion that their quantification provides novel prognostic indicators. While the knowledge base excerpts discuss immune responses in specific hereditary cancers, the TAVILY_SUMMARY provides the direct confirmation for the general statement.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11076352/', 'https://www.ncbi.nlm.nih.gov/books/NBK606527/']"
